Pathologic Evaluation of Syzygium aromaticum Essential Oil Against Pulmonary Aspergillosis in Non-neutropenic Immunosuppressed Rabbits

Pathologic Evaluation of Syzygium aromaticum Essential Oil Against Pulmonary Aspergillosis in Non-neutropenic Immunosuppressed Rabbits | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article Pathologic Evaluation of Syzygium aromaticum Essential Oil Against Pulmonary Aspergillosis in Non-neutropenic Immunosuppressed Rabbits Sara Shokrpoor, Mahya Lalehpoor, Aghil Sharifzadeh, Majid Masoudifard, and 3 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-7941551/v1 This work is licensed under a CC BY 4.0 License Status: Published Journal Publication published 03 Jan, 2026 Read the published version in Scientific Reports → Version 1 posted 13 You are reading this latest preprint version Abstract Aspergillus is a genus of saprophytic fungi which is found in soil, construction equipment, and hospital environments. Invasive aspergillosis occurring in immunocompromised individuals or in patients receiving immunosuppressive therapy is recognized as a major cause of mortality. In the in vitro phase of this study, clove essential oil was prepared by hydrodistillation of clove plant ( Syzygium aromaticum ) dry powder, GC-MS analysis followed by the MIC and MFC determination of clove essential oil were performed. In the in vivo phase, 24 female New Zealand White rabbits were exposed to a conidial suspension of Aspergillus fumigatus ATCC 13073 via the endotracheal route after administration of non-neutropenic immunosuppressive agents (cyclosporine and methylprednisolone). The rabbits were then assigned into four groups: normal saline, Itraconazole, clove essential oil at 20 mg/kg, and clove essential oil at 10 mg/kg, administered orally every 24 hours. Daily monitoring of the rabbits was performed, and CT scans were conducted on days 0, 7, and 13 post-inoculations. On days 7 and 13 post-inoculation, half of the animals were sacrificed. Following this, Macroscopic examinations and sampling were conducted to evaluate bronchoalveolar lavage fluid and lung tissue fungal burden. For microscopical examinations of pulmonary lesions was used H&E staining, immunohistochemistry markers (CD68, CD163, and MPO), and Grocott’s methenamine silver (GMS) staining. Systemic toxicity in other vital organs was also assessed using H&E staining. The clove essential oil, containing 96.81% eugenol, demonstrated acceptable MIC and MFC activity for Aspergillus fumigatus ATCC 13073 , comparable to Itraconazole. In both pre-mortem and post-mortem evaluations, the Itraconazole group and the clove essential oil group at a dose of 20 mg/kg exhibited significant reductions in fungal burden, fungal infection, and pulmonary involvement, without notable systemic toxicity changes in other tissues. Clove essential oil exhibited acceptable efficacy comparable to a commercial azole antifungal agent under both in vitro and in vivo conditions, effectively reducing the fungal burden of Aspergillus fumigatus ATCC 13073 and associated pulmonary lesions without inducing systemic toxicity. Health sciences/Diseases Biological sciences/Drug discovery Health sciences/Medical research Biological sciences/Microbiology Pulmonary aspergillosis Clove essential oil Rabbit Microscopical findings Figures Figure 1 Figure 2 Figure 3 Figure 4 Figure 5 Figure 6 Figure 7 Figure 8 Figure 9 Figure 10 Introduction Aspergillus , a ubiquitous saprophytic fungus, is widely found in soil, building dust, and hospital environments 1 . Aspergillus fumigatus spores continually threaten the respiratory tract by inducing inflammatory responses predominantly mediated by macrophages and epithelial cells 2 . Pulmonary aspergillosis is generally classified into three broad categories: allergic bronchopulmonary aspergillosis, chronic pulmonary aspergillosis, and invasive pulmonary aspergillosis 1 . Invasive aspergillosis (IA) is recognized as a significant cause of morbidity and mortality in severely immunocompromised patients and primarily involves the lungs through inhalation of Aspergillus conidia 3 . Consequently, invasive pulmonary aspergillosis (IPA) is considered a serious and life-threatening infection in patients undergoing immunosuppressive therapies with severe and prolonged neutropenia, such as myelotoxic chemotherapy for cancer treatment 4 . Invasive pulmonary aspergillosis progresses rapidly and has a high mortality rate of up to 50% 1 . The critical role of neutrophils in eliminating Aspergillus conidia has been proven 1 , 5 . Additionally, the efficacy of lysosomes in phagosomes and the acidification of phagosomes determine the capacity of airway epithelial cells to control Aspergillus fumigatus growth. Overall, the airway epithelium demonstrates greater ability to inhibit fungal survival in bronchial cells in comparison with alveolar cells, and specific cell wall mutants of Aspergillus fumigatus can affect phagosome maturation in epithelial cells 6 . Recent years have witnessed an increased incidence of invasive aspergillosis in non-neutropenic patients, including individuals with hematological malignancies undergoing chemotherapy, patients admitted to intensive care unit (ICU), and those treated with corticosteroids were reported 1 , 7 . It is estimated that only one-third of IPA cases are associated with long-term neutropenia 1 . Moreover, the emergence of COVID-19-associated pulmonary aspergillosis in ICU patients has further highlighted the importance of awareness regarding this pathogen 8 . Due to the clinical significance of this disease, extensive research is conducted annually on its pathophysiology, epidemiology, prognostic factors, and treatment methods 9 , 10 . Immunosuppressive therapies, such as cyclosporine administration, are major predisposing factors for IPA 4 . Cyclosporine, a potent immunosuppressant, is commonly used to prevent organ transplant rejection and manage autoimmune disorders 11 . It inhibits T-cell activation, which, while effective in preventing graft-versus-host disease, significantly impairs the immune system’s capacity to combat infections. As a result, patients receiving cyclosporine are at heightened risk for opportunistic infections, with Aspergillus representing one of the most prevalent and life-threatening pathogens 11 . Histopathological evaluation is a crucial tool for studying IPA, particularly for assessing lung tissue damage and disease progression in immunocompromised hosts. Examination of lung tissues under a light microscope allows the identification of pathological changes, including tissue necrosis, inflammation, and fungal hyphae presence all of which are indicative of Aspergillus invasion. Such analysis provides insights into fungal infection mechanisms and host responses, which are essential for developing effective diagnostic and therapeutic strategies 9 , 10 . Within ICU, the revised EORTC/MSG definitions categorize IPA in immunocompromised patients as proven, probable, or possible. Proven IPA requires histopathological confirmation of fungal invasion; probable IPA necessitates a combination of host factors, clinical signs, and positive mycological evidence, and possible IPA is identified by host factors and clinical signs but lacks mycological confirmation 12 , 13 . Many clinically-used antifungal agents are associated with toxicity, drug–drug interactions, lack of fungicidal effect, high cost, and emerging resistance among common fungal pathogens 14 . Therefore, extensive studies have been performed on Aspergillus both in vitro and in vivo 15 . Recent treatment recommendations have been updated emphasizing the combination of first line and second-line therapies, alongside the investigations into novel compounds 16 . Since Aspergillus species are well-known to be resistant to azole antifungal compounds, plant-derived essential oils and their major constituents have been evaluated for antifungal activity 17 . Clove plant ( Syzygium aromaticum ), a member of the Myrtaceae family, is globally among the most valued spices 18 , 19 . This plant contains eugenol, acetyl eugenol, beta-caryophyllene, vanillin, keratolic acid, tannins, and other compounds 19 . Eugenol, - a volatile, colorless to light-yellow, water-soluble phenylpropanoid with a strong odor and taste- constitutes the primary component of clove essential oil. It exhibits insecticidal, antimicrobial, and anti-inflammatory properties 20 and demonstrates potent antifungal activity against A. fumigatus in in vitro studies 14 , 17 , 21 , 22 . In addition to in vitro studies, the establishment of animal models of pulmonary aspergillosis and the design of preclinical studies to investigate antifungal are of great importance 15 , 23 , 24 . Rabbits in particular serve as valuable models due to their susceptibility to respiratory infections and similarities in immune response to humans 15 , 24 , 25 . Pulmonary lesions in immunosuppressed rabbits are classified into three categories: hemorrhagic infarction, neutrophilic, and monocytic lesions 24 , 25 . The use of cyclosporine–methylprednisolone-treated rabbits simulate a non-neutropenic immunocompromised state, providing a relevant model for IPA studies 15 . This study aimed to establish an animal model of invasive pulmonary aspergillosis using standard non-neutropenic immunosuppression methods 15 , 24 , 26 , and to evaluate the antifungal efficacy of clove essential oil in comparison with a conventional antifungal agent regarding in vitro and in vivo aspects. Therefore, the effects as well as therapeutic potency of clove essential oil at two different doses compared to Itraconazole in the direct exposure to fungus Aspergillus fumigatus ATCC 13073 along with treatment of pulmonary aspergillosis in rabbits were investigated clinically, paraclinically, necropsy, mycologically and histopathologically. Materials and Methods Fungal Strain and Inoculum Preparation A standard isolate of Aspergillus fumigatus ( ATCC 13073 ) was used in this study. The cryopreserved stock culture was first thawed at room temperature. To activate the fungus, it was sub-cultured onto potato dextrose agar (PDA) plates and incubated at 28°C for 7 days to promote extensive sporulation and conidia formation 27,28 . The conidia were then harvested by gently flooding the agar surface with sterile saline containing 0.05% Tween 80. The resulting suspension was filtered through sterile gauze to remove hyphal fragments, and the conidial concentration was adjusted using a hemocytometer slide 28 . Extraction and Chemical Analysis of Essential Oil Clove essential oil was extracted from 100 grams of dried Syzygium aromaticum (clove) powder via hydrodistillation for 4 hours using a Clevenger-type apparatus. The collected oil was dehydrated over anhydrous sodium sulfate and stored in an amber-glass vial at 4°C to protect it from light and oxidation until further use 19 . The chemical composition of the essential oil was characterized by gas chromatography–mass spectrometry (GC–MS). The analysis was performed using Thermoquest 2000. The chromatograph was equipped with Hp5 capillary column (30 × 0.25 mmID× 0.25 μm film thickness) and the data were acquired under the following conditions: initial temperature 50°C, program rate 2.5°C, final temperature 265°C and injector temperature 250°C. The carrier gas was helium at the flow rate of 1.1 ml/min, and the split ratio was 1:100. The essential oil was also analysed by GC mass spectrometry (GC/MS) on the same gas chromatograph coupled with MSD5973. The MS was run in the electron ionization mode, using ionization energy of 70 eV and interface temperature was 250°C. The components of essential oils were identified tentatively by comparing their retention indices and mass spectra with those of Wiley 275 Registry of Mass Spectral Data. The relative percentages of the constituents were calculated based on peak areas 19 . Determination of Minimum Inhibitory and Fungicidal Concentrations (MIC/MFC) The minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of clove essential oil against Aspergillus fumigatus ( ATCC 13073 ) were determined according to the reference broth microdilution method 27 . The fungal strain was sub-cultured from a frozen stock onto Sabouraud dextrose agar (SDA) and incubated at 28°C for 5-7 days to promote conidiation. Conidia were harvested by adding 5 mL of sterile saline with 0.05% Tween 80 to the agar surface and gently scraping with a sterile loop. The resulting suspension was vortexed, and the conidial density was adjusted to a concentration of 4 × 10⁴ CFU/mL in RPMI 1640 medium buffered with MOPS, as confirmed by hemocytometer count. Two-fold serial dilutions of the clove essential oil were prepared in RPMI 1640 medium, yielding a concentration range of 0.02 to 20 μL/mL. Aliquots of 100 μL of each dilution were dispensed into the wells of a sterile 96-well microtiter plate. An equal volume (100 μL) of the standardized conidial inoculum was then added to each well. The plate was incubated at 35°C for 48 hours. The MIC was defined as the lowest essential oil concentration that resulted in the complete absence of visible fungal growth. Following the incubation period, 100 μL from each well that showed no visible growth was sub-cultured onto fresh SDA plates. The plates were incubated at 35°C for 48 hours. The MFC was defined as the lowest essential oil concentration that resulted in either no growth or fewer than three colonies on the SDA plate, corresponding to a ≥99.9% reduction in the original inoculum viability, indicating a fungicidal effect. Concentrations that inhibited growth in the broth but did not meet this criterion upon sub-culturing were considered fungistatic. 27 Time-Kill Kinetics Assay The fungicidal kinetics of Syzygium aromaticum essential oil (Clove EO) and itraconazole against Aspergillus fumigatus ( ATCC 13073 ) were evaluated using a time-kill assay according to established methodologies with modifications. A conidial suspension was prepared from a 7-day-old culture grown on Sabouraud Dextrose Agar (SDA) at 28°C. The conidia were harvested by flooding the plate with sterile saline containing 0.05% Tween 80 and gently scraping the surface with a sterile loop. The suspension was adjusted to a final concentration of 4 × 10⁵ CFU/mL in RPMI 1640 medium buffered with MOPS (0.165 M, pH 7.0) using a hemocytometer for quantification. The assay was performed by incubating the conidial suspension with Clove EO and itraconazole at multiple concentrations (e.g., 0.25x, 0.5x and 2x, the Minimum Inhibitory Concentration). A drug-free tube containing only the inoculum in RPMI 1640 medium served as a growth control. All tubes were incubated in a shaking incubator at 35°C. At predetermined time intervals (0, 2, 4, 8, 12, 16, 20, and 24 hours), 100 μL aliquots were removed from each tube. These aliquots were subjected to the fungicidal activity was defined as a ≥99.9% (or a 3-log10) reduction in the CFU/mL compared to the starting inoculum. Time-kill curves were generated by plotting the log10 CFU/mL against time. 28 Animals A total of 24 female New Zealand White rabbits, weighing 1.5–2.5 kg, were obtained. The rabbits were acclimated for at least one week prior to the commencement of the study. The room temperature was maintained at 21 ± 0.5°C with a 12-hour light/dark cycle, and the relative humidity was set at 45%. The animals had access to water and standard rabbit chows. In the current study, all experimental procedures and methods were conducted in accordance with the guidelines of the I.R Iran Ethics Committee for Research on working with Laboratory Animals (ID: IR.UT.VETMED.REC.1401.013) and the ARRIVE guidelines. Establishment of the Non-neutropenic Immunosuppressed Animal Model of Invasive Pulmonary Aspergillosis To establish the animal model, New Zealand white rabbits received cyclosporine (CsA) at a dose of 10 mg/kg/day (0.5 mg/kg during 15 seconds), and methylprednisolone at a dose of 5 mg/kg/day intravenously for 14 consecutive days to induce immunosuppression without neutropenia. 25,26, 29 On the fourth day of the experiment, the fungal inoculum was delivered endotracheally under general anesthesia with ketamine and xylazine. 25, 26, 29, 30 Microorganism and Conidial Suspension To prepare the inoculum, Aspergillus fumigatus strain ATCC 13073 from a frozen isolate was subcultured onto Sabouraud dextrose agar (SDA) and incubated at 37°C until sufficient conidiation was achieved. Subsequently, 5 ml of sterile normal saline containing 0.05% Tween 20 was added to the culture medium under a laminar flow hood. The Aspergillus fumigatus strain ATCC 13073 grown on the medium was gently scraped using a sterile culture loop, and the resulting suspension was collected with a Pasteur pipette. The desired concentration, 1 × 10 8 to 1.25 × 10 8 conidia in a volume of 250 to 350 μl, was adjusted using a hemocytometer slide and serial dilution. 4,26 Antifungal Treatment The rabbits were randomly assigned to four groups: negative control (n = 6), positive control (n = 6), treatment group A (n = 6), and treatment group B (n = 6). Antifungal treatment commenced 24 hours after fungal inoculation and continued until day 12. The negative control group received normal saline at 2 ml/kg, the positive control group received itraconazole at 30 mg/kg, treatment group A received clove essential oil at 10 mg/kg, and treatment group B received clove essential oil at 20 mg/kg. All treatments were administered orally every 24 hours using a syringe, slowly from the side of the mouth. Monitoring and Evaluating Variables Throughout the study, the rabbits were monitored for survival time, as well as the status and extent of lung involvement in living animals. Post-mortem evaluations included the assessment of pulmonary macroscopic lesions, pulmonary and BALF fungal burden, and the presence or absence of systemic cytotoxicity in other vital organs. Daily Monitoring The rabbits were assessed daily for pain and welfare and were monitored for survival until day 13 post-inoculation (24 hours after the final treatment). The rabbit physiognomy scale was employed to evaluate features such as the shape of the nostrils, flattening of the cheeks, position and configuration of the ears, closure of the eyes, and changes in the whiskers and sensitive facial hair. General indicators of pain and distress, including darkening of the nails and feet, pallor of the eyes, closure of the third eyelid, and failure to assume a normal posture, were also recorded. Computing Tomography (CT) scan CT images were acquired using a 2-slice CT scanner with the protocol of a slice thickness of 1-2 mm, a pitch of 0.9, and an ultra-sharp reconstruction Kernel (U90s) in the lung window. Scans were performed on days 0, 7, and 13 post-inoculations on one rabbit from each group under general anesthesia using ketamine and xylazine 29, 30 . The animals were positioned in sternal recumbency, and images were obtained in both sagittal and frontal planes. Post-Mortem Analysis On days 7 and 13 post-inoculation, the animals were euthanized under deep anesthesia via intravenous administration of pentobarbital sodium (60–100 mg/kg) and systematically necropsied to be used for samples and histopathological examination of the lungs as well as other vital organs 30 . Macroscopic (Gross) Examination The lungs were examined for appearance changes, including hyperemia, hemorrhage, tissue consistency, and color. Other vital organs, including the heart, brain, kidneys, liver, and spleen, were inspected for indicators of systemic toxicity. Weighing the Lung tissue The net lung weight of each rabbit was carefully measured and recorded 26 . BALF Fungal Burden BALF was collected from each lung for cytological examination and fungal culture. For this purpose, 10 ml of sterile normal saline was instilled into the lung via the trachea using a 12 ml sterile syringe, repeated twice. The lavage fluid was collected and centrifuged at 400 × g for 10 minutes. The supernatant was discarded, and 2 ml of the pellet was retained. The remaining fluid was vortexed and aliquoted into 100 microliter volumes. 100 microliters of the obtained liquid were mounted on a slide and examined microscopically for the presence or the absence of fungal hyphae. In addition, 100 microliters of a 10⁻¹ dilution was cultured on Sabouraud dextrose agar (SDA). The number of Aspergillus fumigatus colony-forming units in BALF was subsequently enumerated, and CFU/mL was calculated 26 . Lung Fungal Burden To assess fungal burden, a defined portion of tissue was excised from each lung lobe and weighed in the next step. The tissue was then placed in a sterile container and homogenized with sterile normal saline for 30 seconds. dilutions of the homogenized lung (10⁻¹ and 10⁻²) were prepared in sterile normal saline. 100 microliters were then plated on Sabouraud dextrose agar (SDA) and incubated at 37 °C for 24 hours, followed by an additional 24 hur at room temperature. The number of Aspergillus fumigatus colony-forming units (CFU) in each lung lobe was subsequently enumerated, and CFU/g of tissue was calculated 26 . Histopathological Examination The remaining lung tissue was fixed in 10% neutral-buffered formalin for 24-48 hours for histopathological evaluation. Tissue processing was then performed using an automatic tissue processor, and paraffin-embedded tissue blocks were prepared by means of a paraffin dispenser. The tissue sections, with a thickness of 5μm, were then stained with the routine Harris Hematoxylin-Eosin stain 31 . Paraffin-embedded lung samples were further subjected to Gomori methenamine silver (GMS) staining to confirm fungal infection and associated inflammatory responses. Microscopically, pulmonary lesions were assessed for the presence and extent of hemorrhage, hyperemia, necrosis, thrombosis, infiltration and accumulation of inflammatory cells in bronchi, bronchioles, and alveoli, as well as for evidence of vascular fungal invasion. Also, to investigate the composition of inflammatory cells, by using CD68 and CD163 markers for M1 and M2 macrophages, respectively, and MPO (myeloperoxidase) marker for neutrophils, after blocking endogenous peroxidase with H2O2 solution and antigen retrieval with sodium citrate solution at pH=6 and by thermal method, immunohistochemistry was used 32 . The stained sections were examined under a light microscope, and micrographs were captured using a camera. Quantitative analysis of inflammatory cell distribution was performed with ImageJ software. Similarly, to examine the systemic cytotoxic status, sampling of other tissue components such as heart, liver, kidney, spleen and brain was performed. After fixation in 10% neutral buffered formalin, routine hematoxylin-eosin staining slides were prepared and examined for histopathological toxicological criteria under the light microscope 31 . Finally, the study is in accordance with ARRIVE guidelines 33 . Results in vitro Study GC–MS Analysis The GC-MS analysis determined the following components, Table 1. Eugenol was the major component in studied clove essential oil with 96.81%. Table 1. demonstrates most components of clove essential oil used in the study. MIC and MFC Determination MIC and MFC of clove essential oil were 156.25 ppm and 625 ppm, respectively (Fig. 1 A and B). The MIC of Itraconazole was also determined to be 1 μg/mL (Fig. 1 C). Time-Kill Kinetics The time-kill kinetics of clove essential oil and itraconazole were evaluated against Aspergillus fumigatus at concentrations of 2×MIC, MIC, ½×MIC, and ¼×MIC. Both agents exhibited a concentration-dependent fungicidal effect. A pronounced reduction in fungal viability, achieving up to a 2-log10 decrease in colony-forming units (CFU)/mL compared to the growth control, occurred within the first 4 to 12 hours of exposure. This initial rapid kill phase was followed by a period of relative stability in the fungal burden from 12 to 24 hours. Although a continued decline in CFU/mL was observed at the 2×MIC and MIC concentrations during this later phase, the reduction did not constitute an additional logarithmic kill (i.e., a further 99% reduction). These data demonstrate that the primary fungicidal activity of both clove oil and itraconazole under these conditions occurs within the first 12 hours of exposure (Fig. 2). in vivo Study Results CT scan CT scans were performed on days 0, 7, and 13 post-inoculations with Aspergillus fumigatus ATCC 13073 . In the negative control group (normal saline), CT images revealed significant development and progression of nodular pulmonary lesions on days 7 and 13 compared with day 0. Between days 7 and 13, the extent of pulmonary involvement increased further. In contrast, rabbits in the positive control group (Itraconazole) exhibited fewer pulmonary lesions on day 7 post-inoculation than those in the negative control group. Following antifungal treatment, these rabbits demonstrated a favorable response to the treatment, with a reduction in patchy attenuation within the lung parenchyma between days 7 and 13. Rabbits treated with clove essential oil also showed fewer pulmonary lesions on day 7 compared with the negative control group. The higher dose (20 mg/kg) was associated with fewer lesions than the lower dose (10 mg/kg). Between days 7 and 13, lung lobe involvement in the clove-treated groups remained largely stable. Despite evident reductions in patchy attenuation and nodular pneumonia, the lesions demonstrated minimal progression, with signs of ongoing healing and a subtle decrease in lesion density. Overall, a minor difference in treatment response was observed between rabbits receiving Itraconazole and those treated with clove essential oil at 20 mg/kg on day 7. No statistically significant difference was observed between the two groups at this time point. However, by day 13 post-inoculation, the positive control group (Itraconazole) displayed a faster and better recovery (Fig. 3). Macroscopic Examination for Cytotoxicity Macroscopic evaluation of vital organs, including the heart, kidneys, liver, spleen, and brain, following the administration of normal saline, Itraconazole, and clove essential oil at the studied doses, revealed no significant differences in lesions or signs of systemic cytotoxicity. All examined tissues exhibited normal histological structure. Macroscopic examination of the lung Macroscopic examination of lung tissue in rabbits from different groups on days 7 and 13 post inoculation to Aspergillus fumigatus strain ATCC 13073 , demonstrated a significant involvement of the lung lobes on day 7 in the form of small dark red hemorrhagic areas of varying sizes, the formation of nodules indicating an inflammatory response a variety of dark red spotted lesions, along with firm, aggregated, or confluent gray-to-white nodular lesions. Additionally, Fewer firm, flattened, confluent gray-to-red lesions were scattered throughout the lungs. On day 13 post inoculation to the fungus, nodules indicating an inflammatory response were formed. These were firm, confluent, flattened gray-to-red lesions, and less firm, aggregated, or confluent gray-to-white nodules and areas of hemorrhage. An increase was shown in the extent of pulmonary involvement in the negative control group (normal saline). In contrast, concerning the groups treated with Itraconazole and clove essential oil at doses of 20 mg/kg and 10 mg/kg, respectively, the extent of pulmonary involvement either decreased on day 13 post-inoculation or the extent of lesions did not progress. Comparison of mean lung weights between the study groups on days 7 and 13 The results revealed a significant difference between the mean lung weights of the rabbits in the study groups, regardless of time. Tukey's post hoc comparisons indicated that the mean lung weights in the Itraconazole group were significantly lower than those in the negative control group and the group treated with clove essential oil at a dose of 10 mg/kg (p0.05). Likewise, no significant difference was observed between the mean lung weights of the other groups (p>0.05). Regarding time, there was also no significant difference between the average lung weights of rabbits on days 7 and 13 post-inoculation, regardless of group (p>0.05). (Fig. 4 A) Fungal burden of BALF and lung tissue between the study groups on days 7 and 13 The analysis of the mean logarithm of fungal burden in the bronchoalveolar lavage fluid of the groups indicated a significant difference between the groups, regardless of time (p<0.05). Tukey's post hoc comparisons showed that the mean logarithm of BALF fungal burden in the Itraconazole group was substantially lower than that to the negative control group (p 0.05). Furthermore, comparing the mean logarithm of BALF fungal burden at different times (irrespective of the treatment group), indicated no significant differences between days 7 and 13 post inoculation (p>0.05). (Fig. 4 B) Regarding the comparison of the mean logarithm of fungal burden of the rabbit lung of the studied groups, the results showed that there was a significant difference between them regardless of time (p<0.001). Tukey's post hoc comparisons showed that the mean logarithm of lung fungal burden in the Itraconazole group was significantly lower compared to the other groups (p0.05). Also, by comparing the mean logarithm of lung fungal burden at different times (regardless of group), it was observed no significant difference between days 7 and 13 post-inoculation (p>0.05). (Fig. 4 C) Histopathological examination of lung tissue Histopathological examination of various lung lobes of the rabbits studied, including the left lung lobes (anterior and posterior) and the right lung lobes (anterior, middle, posterior and accessory) was performed at two-time intervals of 7- and 13-days post-inoculation to the Aspergillus fumigatus strain ATCC 13073 . In order to assess the extent of lung tissue involvement, inflammatory response and other pathological lesions with three criteria of severe, moderate and mild and to calculate the percentage of lung lobe involvement compared to the typical structure of rabbit lung tissue, indicated that the infiltration of inflammatory cells comprised a significant number of neutrophils (heterophiles) and a smaller number of foamy alveolar macrophages, necrosis and cellular debris (necrotizing pneumonia), focal hemorrhage, edema, fibrin deposition, Langhans giant cells, infiltration of lymphocytes and the formation of asteroid bodies to a small extent in the samples corresponding to the seventh day after exposure. Exposure to Aspergillus fumigatus strain ATCC 13073 , indicative of an acute to subacute inflammatory phase, was evident. The comparison of the above findings among the samples related to each group indicated that the highest level of involvement and pathological lung lesions was among rabbits in the negative control group without effective treatment (normal saline). In contrast, the positive control group (with itraconazole) showed the lowest level of lung involvement and pathological lesions caused by induced fungal infection and the inflammatory response associated with it. It is worth noting that in the groups treated with clove essential oil, the extent of lesions and inflammatory response in the lung tissue was lower in rabbits receiving a dose of 20 mg/kg compared to the dose of 10 mg/kg. (Fig. 5) In the examination of samples from day 13 after exposure to Aspergillus fumigatus strain ATCC 13073 , a shift in the proportion of inflammatory cells was observed with an increase in the number of macrophages along with the formation of Langhans giant cells and numerous foreign bodies, infiltration of neutrophils, lymphoplasmacytic bronchiolitis, necrotic areas and cellular debris, hyperplasia of type II pneumocytes and the formation of abundant asteroid bodies consisting of small hyphae and ungerminated conidia of the fungus surrounded by inflammatory cells of neutrophils and epithelioid macrophages and deposition of amorphous eosinophilic protein materials in a radial and spheroidal arrangement indicating the onset of a chronic inflammatory response and a pyogranulomatous inflammatory reaction. In comparison between the studied groups, lung lesions and inflammatory response in rabbits in the negative control group without effective treatment (normal saline) showed the highest levels, and with time, the progression of pathological lesions due to the inflammatory response to the induced fungal infection was evident. The positive control group (with itraconazole) had the lowest involvement in lung tissue, and with time and drug administration, the severity of lung lesions decreased from day 7 to 13. In the groups receiving clove essential oil, the involvement of lung tissue at a dose of 20 mg/kg was generally less than that at a dose of 10 mg/kg, and the effects of improvement and reduction of inflammatory response from day 7 to 13 at a dose of 20 mg/kg were significantly greater than those at a dose of 10 mg/kg. (Fig. 6) Histochemistry and Immunohistochemistry examination of lungs The presence of fungal structures scattered within rabbits’ lungs and related inflammatory responses was confirmed by using GMS staining. Examination of the expression of the CD68 marker associated with M1 macrophages in lung samples on day 13 after exposure to Aspergillus fumigatus strain ATCC 13073 in the studied groups showed that the normal saline group had higher expressions compared to other groups due to the severe inflammatory response to the fungus. After that, the clove essential oil group at a dose of 10 mg/kg had significant marker expression, while the itraconazole and clove essential oil groups at a dose of 20 mg/kg had the lowest levels, respectively. Examination of the expression of the CD163 marker associated with M2 macrophages in lung samples on day 13 after exposure to Aspergillus fumigatus strain ATCC 13073 in the studied groups showed that in the normal saline group, due to greater fungal contamination and the effect of Aspergillus fumigatus on the differentiation of M1 to M2 macrophages, the expression of the marker was higher than in the other groups, and in the itraconazole and clove essential oil groups at doses of 20 mg/kg and 10 mg/kg, respectively, it was lower. Examination of the expression of MPO marker as an indicator for neutrophil differentiation in lung samples on day 13 after exposure to Aspergillus fumigatus strain ATCC 13073 in the studied groups showed that the marker expression was lower in the itraconazole group as well as the clove essential oil group at a dose of 20 mg/kg than in the other groups. However, no notable changes were observed between the normal saline and clove essential oil groups at a dose of 10 mg/kg (Fig. 7). Comparison of lung lesions between the study groups on days 7 and 13 Figure shows the extent of lung involvement as determined by histopathology and macrophages type 1 and 2 and neutrophils specific markers in the control and clove essential oil-treated groups on days 7 and 13 post inoculation. Overall, Tukey's post-hoc comparisons revealed that pulmonary lesions in rabbits being treated with Itraconazole were significantly less compared to those in the negative control group (without effective treatment) and the clove essential oil-treated group at a dose of 10 mg/kg (p0.05). Additionally, no significant differences were detected between the pulmonary lesions in other groups (p>0.05). Regarding time, there was no significant difference between the pulmonary lesions of rabbits on days 7 and 13 post inoculation, regardless of treatment group (p>0.05) (Fig. 8). Microscopic examination of other tissue components Microscopic examination of the heart, kidney, liver, spleen, and brain of rabbits treated with clove essential oil at the studied doses (including two doses of 10 and 20 mg/kg), normal saline and Itraconazole treated groups on days 7 and 13 post-Inoculation, revealed ordinary histologic appearance. No evidence of systemic cytotoxicity including hemorrhage and necrosis was observed and recorded in any group. (Fig. 9 and 10) Discussion In the current study, clove essential oil, with eugenol being the main active ingredient, exhibited a high volume of 96.81% which exceeded all the previously reported studies (85–90%) 14, 19 . Due to the numerous properties of plant compounds, particularly clove plant, in destroying various microorganisms such as bacteria and fungi 35 , as well as considering the increased resistance of Aspergillus fumigatus to azole antifungal drugs following some mutations such as TR34/L98H and TR46/Y121F/T289A 36 , extensive studies have been conducted to confirm the significant effects of minimal concentrations of plant compounds on bactericidal and fungicidal activity, particularly on Aspergillus fumigatus 27 . Both pure and nanoemulsion forms of clove essential oil have revealed significant bactericidal properties 20 . In the current study, MFC and MIC of clove essential oil as an herbal compound with a high percentage of eugenol showed satisfactory efficiency against Aspergillus fumigatus strain ATCC 13073 comparable to Itraconazole as a commercial antifungal drug. For which the MIC for Itraconazole was calculated to be 1 µg/ml. This was notable as in the previous studies conducted on isolated Aspergillus fumigatus isolates with the TR34/L98H mutation, all had MICs greater than 1 µg/ml for Itraconazole and 97% had MICs greater than 1 µg/mL and more than 0.25 µg/mL for Voriconazole and Posaconazole, respectively. Also, all the isolated Aspergillus fumigatus isolates with the TR46/Y121F/T289A mutation had MICs greater than 1 µg/mL for Voriconazole, 76% had MICs greater than 1 µg/mL and 35% had MICs greater than 0.25 µg/mL for Itraconazole and Posaconazole, respectively 36 . Examination of the time-killing assay curve of Aspergillus fumigatus strain ATCC 13073 for diverse concentrations of clove essential oil represented a similar downward trend in fungal burden and decrease (2Log) from 4 to 12 hours along with an insignificant decline from 12 to 24 hours after inoculation compared to the control sample in comparison with Itraconazole different concentrations. Similar evaluations were also reported in a study using tea tree essential oil. The pure concentration of the essential oil showed the most significant and fastest impacts with a decline of about 4Log from the initial hours of exposure (4 hours), and the dilutions showed a slower downward trend 28 . In Another study in also found that clove essential oil was able to show effective performance in controlling fungal growth and mycotoxin production in different strains of Aspergillus 37 . The fungicidal and bactericidal effects of clove essential oil at various concentrations against Candida albicans , Escherichia coli , and Staphylococcus aureus had also been confirmed in previous studies 38 . In addition to extensive, in vitro investigations have been conducted on Aspergillus spp., in vivo studies utilizing animal models have been increased 15 . Also, today, antifungal treatment recommendations have been updated in combination of first-line and second-line medicines. Meanwhile, increasing attention has been paid to the use of new methods and combinations 16 . A very high mortality rate was observed in the method of creating a pulmonary aspergillosis model with immunosuppression and persistent neutropenia in the groups without effective treatment 24 , 25 , 26 , whereas in non-neutropenic immunosuppression method, the mortality rate of rabbits of negative control group reached zero. In addition to finding new antifungal agents, concerns regarding to establishing a rapid and definitive method for diagnosing invasive pulmonary aspergillosis and achieving a less invasive procedure for initiating antifungal treatments have caused diverse techniques such as molecular imaging and PET by using animal models have been evaluated 39 , 40 . In other similar studies, conducted on New Zealand White rabbits and using Aspergillus spp. such as A . fumigatus and A . tereus , CT scan images played an important role as a diagnostic method at different time points 29 , 41 . CT scans have also been recognized in non-neutropenic patients with nodular lesions as a diagnostic method for pulmonary aspergillosis 1 , 42 . In the current study, rabbits’ CT scans have exhibited the relatively healthy lung appearance change to the involvement of various lobes after endotracheal conidial suspension inoculation. Its extension was noticeable in the negative control group. Nevertheless, in other groups treated with Itraconazole and clove essential oil, respectively, at a dose of 20 mg/kg and 10 mg/kg, less pulmonary lesions and inflammatory response, and following less nodular pulmonary involvement were evident due to their antifungal effects. After 13 days of inoculation, a slight upward trend in pulmonary lesions was observed in the negative control group, indicating the lack of effective treatment administration in this group, whereas a reduction in the pulmonary involvement and lesions indicating the significant effectiveness of the treatment in the Itraconazole group was observed. However, the group clove essential oil at dose 20 mg/kg was relatively similar at the Itraconazole group at day 7 posy-inoculation, the changes from day 7 to day 13 were insignificant in groups treated with clove essential oil. However, the lack of progression of the inflammatory response accompanied by a gentle healing process in the lung tissue at the time of using clove essential oil has been noticed. No Aspergillus fumigatus hyphae were observed in the examination of bronchoalveolar lavage fluid under a light microscope, which is due to the type of immunosuppression without neutropenia, where the presence of neutrophils prevented the creation of abundant fungal hyphae compared to the immunosuppression method with continuous neutropenia 5 , 26 , 29 . The lung weight mean analysis revealed that positive control group with Itraconazole treatment had a lower mean weight, and it decreased with continued treatment. In the clove essential oil treatment groups, the mean lung weight in the group with a dose of 20 mg/kg and 10 mg/kg was respectively less than the negative control group without effective treatment and greater than the positive control group receiving Itraconazole. This reduction in mean lung weight was also evident on days 7 to 13. In other studies, conducted using immunosuppressed rabbits with persistent neutropenia and without neutropenia, a similar condition was observed in which a rise in lung weight mean among control groups without effective treatment up to more than 45 g and up to 20 g in samples treated with commercial drugs during the experiment was evident 4 , 24 , 26 , 41 . Similar to lung weight mean, generally BALF and lung lobes fungal burden in the group without effective treatment recorded the highest and had an upward trend from day 7 to 13 post-inoculation. In contrast, the lowest fungal burden belonged to the group with Itraconazole treatment which decreased from day 7 to 13 post-inoculation consistently. The groups treated with clove essential oil placed between these two controlled groups, and the group treated with a dose of 20 mg/kg indicated more efficient fungal burden reduction. In a study with inducing pulmonary infection in Balb C mice using intratracheal administration of lipopolysaccharide, the aqueous extract of clove plant administered intraperitoneally reduced the number of neutrophils and protein leakage into the bronchoalveolar lavage fluid significantly. In addition, in vitro study has exhibited positive effects of clove on reducing MPO activity 43 . In other similar studies, the control group without effective treatment had the highest fungal burden and the other groups treated with different agents had a lower fungal burden 4 , 26 , 41 . Vital organs’ examination in two ways of macroscopic and microscopic showed no signs of cellular and systemic toxicity due to using clove essential oil compared to the control groups. In the other studies conducted, no evidence of cytotoxicity has been reported so far 35 , 44 . In addition, the absence of subchronic toxicity and mutagenicity has been confirmed concerning the polyphenolic extract of clove seeds 45 . In a similar attitude to using herbal compounds, extensive studies exist one of which has revealed the active ingredient cinnamaldehyde, obtained from the essential oil of cinnamon from the Lauraceae family, can have a significant antifungal effect in an animal model of invasive pulmonary aspergillosis in immunosuppressed ICR mice 46 . Another study, however, revealed a significant effect in eliminating Aspergillus and reducing damage to lung tissue silver nanoparticles from the essential oil of Artemisia sieberi in Swiss albino mice after inducing immunosuppression with neutropenia and infection with the fungus Aspergillus fumigatus by intranasal administration 47 . In another similar study, the antifungal activity of gold nanoparticles of Leptadena hastata essential oil was investigated and confirmed in Swiss albino mice 48 . Another example of these studies is the demonstration of the antifungal effect of Calotropis gigantean extract in a model of invasive pulmonary aspergillosis in neutropenic mice 49 . Not only have herbal agents’ efficiency in antifungal therapy been evaluated, but also their other potentials particularly about clove plant have been of great interests. So, in a study, it was found that the use of clove essential oil encapsulated by nanofibers shows sound effects on wound healing and antimicrobial activity against Escherichia coli and Staphylococcus aureus 50 . In addition to its bactericidal properties, eugenol has been shown having properties in eliminating parasites such as Giardia lamblia , Fasciola gigantica , Haemonchus contortus , and Schistosoma mansoni 51 . In this regard, the relative effectiveness of clove essential oil in improving liver lesions was observed in a study which was conducted using various plant essential oils, including clove essential oil, on rabbits infected with Eimeria estidae 52 . In another study using cold-pressed clove oil, its protective properties against liver cells being damaged by CCL4 were noted, which may indicate that clove products, in addition to not having toxic effects and causing toxicity lesions, have significant effectiveness in improving hepatotoxic lesions induced, probably due to antioxidant compounds 53 . In a study in 2016, the protective effect of clove powder was also evident in rabbits, as in the group that first received paracetamol, liver enzymes including ALT, AST, GGT, ALP and LDH substantially increased after receiving clove powder, and decreased after administration. No changes were observed in the group that received it simultaneously 54 . In a study on rats in which diabetes mellitus was induced, the anti-hyperglycemic effects of aqueous extracts of various plants, including Syzgium cumini (Jamun), were evaluated. The results of this study confirmed the reducing effect on blood sugar levels and weight changes in diabetic rats 55 . In another study, clove essential oil emulsion showed significant antidiabetic properties using alpha-amylase and starch enzymes 56 . In a study, in rats been induced with oxidative stress by H2O2, administration of clove essential oil resulted in positive effects in brain, liver, and kidney tissues, as well as blood biochemical indicators 57 . Clove essential oil is also known as an antioxidant compound in food and pharmaceutical compositions by increasing the shelf life and maintaining their nutritional properties 58 . In a study, it was found that low doses of clove essential oil could be effective in improving and controlling oxidative stress, apoptosis, and excessive autophagy 59 . In addition, in another study, it was found that short-term consumption of clove essential oil can have antidepressant properties and long-term consumption has anti-stress properties by improving the hippocampal pERK1/2-pCREB-BDNF pathway in rats 60 . In current study, in the macroscopic and microscopic examination of lung tissue, pulmonary lesions in the negative control group were much more severe compared with the other groups accompanied by an upward trend from day 7 to 13 post-inoculation. Conversely, the positive control group being treated with Itraconazole showed the mildest pulmonary lesions with a declining and recovery tendency from day 7 to 13 post-inoculation. The groups treated with clove essential oil the extent and following reduction of pulmonary lesions was generally slightly greater in the group treated with a dose of 20 mg/kg. Comparison of histopathological findings of the current study with others represented similar pulmonary lesions. As in studies by using immunosuppressed rabbits with both non-neutropenic and persistent neutropenia and treated with the commercial antifungal drugs such as amphotericin B, extensive fungal hyphal formation and extensive tissue necrosis with vascular infiltration and extensive hemorrhage and vascular thrombosis without significant inflammatory cell infiltration were observed in the persistent neutropenic groups compared to untreated control rabbits without neutropenia. However, in the non-neutropenic groups, the predominant lesions were inflammatory cell accumulation in the form of granulomas containing neutrophils and macrophages, necrosis and without extensive fungal hyphal formation. In the treated rabbits, the group of immunosuppressed rabbits without neutropenia also showed a better condition 24 , 25 , 26 . In addition, the type M1 macrophages’ ratio in the negative control group was higher than in the other groups, which could be due to the high level of fungal infection and burden. The population of M2 macrophages was also higher in the negative control group than in the other groups due to the effect of the fungus regarding higher burden. It should be noted that it has been shown that Aspergillus fumigatus can cause a change in the phenotype of activated macrophages to M2 type by upregulating M2 macrophage markers such as transcripts of the gene encoding arginase-1 (Arg1), Ym1, and CD206 5 . This was consistent with the control group without effective treatment. In the treated groups, itraconazole, clove essential oil 20 mg/kg and 10 mg/kg groups were in better condition and antigen expression was lower, respectively. The expression of neutrophil-specific marker was relatively analogous related to extension of pulmonary involvement and fungal burden in diverse groups. It should be noted that the effect of clove essential oil in regulating the immune response has been investigated and confirmed in both the humoral and cell-mediated immune systems 61 . It was also determined that the components of clove can suppress the release of interferon gamma, and induce the secretion of interleukins 4 and 10, as well as TGF-B and as a result can suppress T lymphocyte cellular immunity and increase humoral immune responses, so that the cytokine pattern changes towards Th2 and regulatory responses and increases humoral immune cytokines 62 . Notwithstanding most pathological findings has been related to experimental studies, a case report study has represented the pulmonary lesions including scattered nodular lesions throughout the lungs on macroscopic examination and the presence of multiple pyogranulomatous lesions with the formation of asteroid bodies, infiltration of neutrophils, epithelioid macrophages, and the formation of multinucleated giant cells on microscopic examination of apparently healthy rabbits which infected by Aspergillus 63 . Conclusion Summarily, the current study represented that clove essential oil had a significant and important effectiveness in inhibiting the growth and even eliminating Aspergillus fumigatus strain ATCC 13073 , as a filamentous fungus, compared to Itraconazole, as a commercial medicine, from the azole family in in vitro experiment. In in vivo experiments, the findings related to CT scan images, lung tissue weight, bronchoalveolar lavage fluid and lung tissue fungal burden, and macroscopic and microscopic lung examination were very consistent, and an increasing trend was observed in the negative control group without receiving effective treatment, and a decreasing trend and improvement were observed in the groups treated with Itraconazole and different doses of clove essential oil in two time periods of 7 and 13 days post-inoculation to Aspergillus fumigatus strain ATCC 13073 , even though the changes sometimes were slight and differences might be scant between them. It can also be noted that the findings of the current study were consistent with most other studies, both in vitro and in vivo. An Essential point in this study was that although Itraconazole showed more significant results in terms of reducing the fungal burden in the tissue and reducing the extent of pulmonary involvement and lesions than other groups, clove essential oil without causing symptoms of systemic toxicity at a higher dose exhibited relatively better performance compared to a lower dose. Both groups treated with clove essential oil showed effective results compared to the negative control group without receiving effective treatment. This could suggest that if clove essential oil were administered at higher doses, different time intervals, or different formulations, better results might be observed in reducing the fungal burden, inflammatory response, and pulmonary lesions. The following are suggestions for conducting additional studies in this field, such as using other forms of clove essential oil to improve absorption and performance, such as Nano-compounds and emulsions, increasing the drug dose or administration intervals, using a combination of a commercial drug and clove essential oil, and comparing the performance of clove essential oil in reducing fungal lesions in two different groups of filamentous and yeast fungi. Declarations Author Contribution S.Sh.: Conceptualization, Investigation, Formal analysis, Methodology, Histopathological investigations, Validation, Visualization, Project administration, Writing - Review and Editing. M.L.: Conceptualization, Original draft, Investigation, Formal analysis, Methodology, Validation, Visualization, Software, Writing - Review and Editing, Molecular investigations. A.Sh.: Conceptualization, Investigation, Formal analysis, Methodology, Molecular investigations, Writing, Review and Editing. M.M.: CT scans investigations, Review and Editing, Conceptualization, Investigation, Formal analysis, Methodology. F.S.: Conceptualization, Review and Editing. R.I.N.: Daily monitoring, Intubation. Gh.V.: Daily Monitoring, Drug injection. All authors have read and agreed to the final version of the manuscript. Acknowledgement The authors wish to express their appreciation to everyone that assists us in this study. Data Availability The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request. References Kanj, A., Abdallah, N. & Soubani, A. O. The spectrum of pulmonary aspergillosis. Respir. Med . 141, 121-131. https://doi.org/10.1016/j.rmed.2018.06.029 (2018). Bouyssi, A. et al. Characterization of Lung Inflammatory Response to Aspergillus fumigatus Spores. J. Fungi (Basel). 17 , 682. https://doi.org/10.3390/jof9060682 (2023). Ullmann, I., Aregger, A., Leip, S. L. & Zimmerli, S. Caspofungin Cerebral Penetration and Therapeutic Efficacy in Experimental Cerebral Aspergillosis. Microbiol. Spectr . 10, e02753-21. https://doi.org/10.1128/spectrum.02753-21 (2022). Petraitis, V. et al . Combination Therapy with Ibrexafungerp (Formerly SCY-078), a First-in-Class Triterpenoid Inhibitor of (1→3)-β-D-Glucan Synthesis, and Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis. Antimicrob. Agents. Ch . 64, e02429-19. https://doi.org/10.1128/aac.02429-19 (2020). Xu, S. &Shinohara, M. L. Tissue-Resident Macrophages in Fungal infections. Front. Immunol . 8, 01798. https://doi.org/10.3389/fimmu.2017.01798 (2017). Ben-Ghazzi, N. et al . Characterisation of Aspergillus fumigatus Endocytic Trafficking within Airway Epithelial Cells Using High-Resolution Automated Quantitative Confocal Microscopy. J. Fungi (Basel). 7, 454. https://doi.org/10.3390/jof7060454 (2021). Bassetti, M. et al . How to manage aspergillosis in non-neutropenic intensive care unit patients. Crit. Care. 18, 458. https://doi.org/10.1186/s13054-014-0458-4 (2014). Skóra, M. et al . COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit Patients from Poland. J. Fungi . 9, 666. https://doi.org/10.3390/jof9060666 (2023). Ledoux, M. P. et al . Invasive Pulmonary Aspergillosis. Semin. Respir. Crit. Care Med . 41, 80-98. https://doi.org/10.1055/s-0039-3401990 (2020). Shibuya, k. et al. Pathophysiology of pulmonary aspergillosis. J Infect Chemother . 10, 138-145. https://doi.org/10.1007/s10156-004-0315-5 (2004). Gaffney, S., Kelly, D.M., Rameli, P.M., Kelleher, E. & Martin-Loeches, I. Invasive pulmonary aspergillosis in the intensive care unit: current challenges and best practices. Acta Pathol. Microbiol. Scand. 131, 654-667. https://doi.org/10.1111/apm.13316 (2023) Trof, R. J., Beishuizen, A., Debets-Ossenkopp, Y. J., Girbes, A. R. J. & Groeneveld, A. B. J. Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients. Intensive. Care. Med . 33, 1694-1703. https://doi.org/10.1007/s00134-007-0791-z (2007). Rishi, A. et al . Invasive Pulmonary Aspergillosis in Critically Ill Apparently Immunocompetent Patients. Clin. Pulm. Med. 23, 184-187. https://doi.org/10.1097/CPM.0000000000000161 (2016) Pinto, E., Vale-Silva, L., Cavaleiro, C., & Salgueiro, L. Antifungal activity of the clove essential oil from Syzygium aromaticum on Candida, Aspergillus and dermatophyte species . J. Med. Microbiol. 58, 1454-1462. https://doi.org/10.1099/jmm.0.010538-0 (2009). Walsh, T. J., Petraitiene, R., & Petraitis, V. Modeling Invasive Aspergillosis: How Close Are Predicted Antifungal Targets?. J. Fungi. 6, 198. https://doi.org/10.3390/jof6040198 (2020). Brunet, K. & Rammaert, B. Mucormycosis treatment: recommendations, latest advances, and perspectives. J. Mycol. Med. 30, 101007. https://doi.org/10.1016/j.mycmed.2020.101007 (2020). Natu, K. N., & Tatke, P. A. Essential oils-prospective candidates for antifungal treatment?. J. Essent. Oil Res . 31, 347-360. https://doi.org/10.1080/10412905.2019.1604437 (2019). Niazi, M. K. et al . Therapeutic and Nutritional Effect of Clove: A Miracle Spice. Pak. biomed. j . 5, 12-15. https://doi.org/10.54393/pbmj.v5i9.798 (2022). Idowu, S., Adekoya, A.E., Igiehon, O.O. & Idowu, A.T. Clove ( Syzygium aromaticum ) spices: A review on their bioactivities, current use, and potential application in dairy products. J. Food. Meas. Charact . 15 , 3419-3435. https://doi.org/10.1007/s11694-021-00915-9 (2021). Haro-González, J.N., Schlienger de Alba, B.N., MartínezVelázquez, M., Castillo-Herrera, G.A. & Espinosa-Andrews, H. Optimization of Clove Oil Nanoemulsions: Evaluation of Antioxidant, Antimicrobial, and Anticancer Properties. Colloids. Interfaces . 7, 64. https://doi.org/10.3390/colloids7040064 (2023). Khan, M. S. A. & Ahmad, I. In vitro antifungal, anti-elastase and anti-keratinase activity of essential oils of Cinnamomum-, Syzygium- and Cymbopogon-species against Aspergillus fumigatus and Trichophyton rubrum. Phytomedicine. 19, 48-55. https://doi.org/10.1016/j.phymed.2011.07.005 (2011). Uniyal, V., Bhatt, R. P., Saxena, S. & Talwar, A. Antifungal activity of essential oils and their volatile constituents against respiratory tract pathogens causing Aspergilloma and Aspergillosis by gaseous contact. J. Appl. Nat. Sci. 4, 65-70. (2012). Patterson, T. F. The future of animal models of invasive aspergillosis. Med. Mycol. 43, 115-119. https://doi.org/10.1080/13693780400029429 (2005). Berenguer, J. et al . Pathogenesis of Pulmonary Aspergillosis Granulocytopenia versus Cyclosporine and Methylprednisolone-Induced Immunosuppression. Am. J. Respir. Crit. Care Med. 152, 1079-1086 https://doi.org/10.1164/ajrccm.152.3.7663787 (1995). Berenguer J, et al . Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma. Antimicrob. Agents. Chemother . 38, 1303-8. https://doi.org/10.1128/AAC.38.6.1303 (1994) Petraitiene, R., Petraitis, V., Bacher, J. D., Finkelman, M. A. & Walsh, T. J. Effects of host response and antifungal therapy on serum and BAL levels of galactomannan and (1→3)-β-D-glucan in experimental invasive pulmonary aspergillosis. Med. Mycol. 53, 558-568. https://doi.org/10.1093/mmy/myv034 (2015). Suleiman, M. M., McGaw, L. J., Naidoo, V. & Eloff, J. N. Evaluation of several tree species for activity against the animal fungal pathogen Aspergillus fumigatus. S Afr J Bot. 76, 64-71. https://doi.org/10.1016/j.sajb.2009.07.001 (2010). Homeyer, D. C. et al . In Vitro activity of Melaleuca alternifolia (tea tree) oil on filamentous fungi and toxicity to human cells. Med Mycol . 53, 285-294. https://doi.org/10.1093/mmy/myu072 (2015). Walsh, T.J. et al. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B. J. Infect. Dis. 188, 305-319. https://doi.org/10.1086/377210 (2003). Leary, S . et al. AVMA Guidelines for the Euthanasia of Animals: 2020 Edition. American Veterinary Medical Association. 1-121. (2020) Luna, L.G. Manual of histological staining methods of the armed forces Institute of Pathology . In: Manual of histologic staining methods of the Armed Forces Institute of Pathology (1968). Taylor, C.R., Shi, S.R., Barr, N.J. & Wu, N. Techniques of immunohistochemistry: principles, pitfalls, and standardization. In : Diagnostic Immunohistochemistry (ed. Dabbs, D.J) (New York, NY, 2002). Du Sert, N.P. et al . Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLoS. Boil . 18, e3000411. https://doi.org/10.1371/journal.pbio.3000411 (2020). Lalepoor, M., Shokrpoor, S., Sasani, F., Sharifzadeh, A. & Masoudifard ,M. Histopathological Assessment of Cyclosporine and Methylprednisolone-Induced Invasive Pulmonary Aspergillosis in Rabbits, Iran. J. Vet. Med . https://doi.org/10.22059/ijvm.2025.389435.1005734 (2025). Xue Q, Xiang Z, Wang S, Cong Z, Gao P and Liu X Recent advances in nutritional composition, phytochemistry, bioactive, and potential applications of Syzygium aromaticum L. (Myrtaceae). Front. Nutr. 9 ,1002147. https://doi.org/10.3389/fnut.2022.1002147 (2022). Buil, J.B., Hagen, F., Chowdhary, A., Verweij, P.E. & Meis, J.F. Itraconazole, Voriconazole, and Posaconazole CLSI MIC Distributions for Wild-Type and Azole-Resistant Aspergillus fumigatus Isolates. J Fungi (Basel). 4, 103. https://doi.org/10.3390/jof4030103 (2018). Laaziz, A. et al . Activity of essential oils from Syzygium aromaticum and Rosmarinus officinalis against growth and ochratoxin A production by Aspergillus tubingensis and Aspergillus luchuensis from Moroccan grapes. Phytopathol. Mediterr . 61, 299-310. https://doi.org/10.36253/phyto-12841 (2022). Suflet, D.M. et al . Chitosan–Oxidized Pullulan Hydrogels Loaded with Essential Clove Oil: Synthesis, Characterization, Antioxidant and Antimicrobial Properties. gels . 10, 227. https://doi.org/10.3390/gels10040227 (2024). Misslinger, M. et al . Desferrioxamine B-Mediated Pre-Clinical In Vivo Imaging of Infection by the Mold Fungus Aspergillus fumigatus. J Fungi (Basel). 7, 734. https://doi.org/10.3390/jof7090734 (2021). Gunzer, M., Thornton, C.R. & Beziere, N. Advances in the In Vivo Molecular Imaging of Invasive Aspergillosis. J Fungi (Basel). 6, 338. https://doi.org/10.3390/jof6040338 (2020). Petraitis, V. et al . Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin. J Infect Dis. 187, 1834-1843. https://doi.org/10.1086/375420 (2003). Bassetti, M., Carnelutti, A., Righi, E., Corcione, S. & De Rosa, F. G. Current Pharmacological Treatment of Pulmonary Aspergillosis. Clin. Pulm. Med . 22, 205-214. https://doi.org/10.1097/CPM.0000000000000096 (2015). Chniguira, A., Ziouda, F., Marzaiolic, V., El-Bennac, J. & Bachoual, R. Syzygium aromaticum aqueous extract inhibits human neutrophils myeloperoxidase and protects mice from LPS-induced lung inflammation. Pharm. Biol. 1, 56-64 https://doi.org/10.1080/13880209.2018.1557697 (2018). Afanyibo, Y.G. et al. Toxicity and antioxidant activity of Syzygium aromaticum, Mondia whitei, Carissa spinarum and Caesalpinia bonduc. J Phytopharmacol. 8, 124-128. https://doi.org/10.31254/phyto.2019.8307 (2019). Vijayasteltar, L., Gopinathan, Nair, G., Balu Maliakel, b. & Ramadasan Kuttana Krishnakumar I.M. Safety assessment of a standardized polyphenolic extract of clove buds: Subchronic toxicity and mutagenicity studies. Toxicol. Rep . 3, 439-449. https://doi.org/10.1016/j.toxrep.2016.04.001 (2016). Liua, X., Luo, J., Dengc, J., Li, J., & Wang, G. In vivo investigation of antimicrobial effects of cinnamaldehyde using immunosuppressed ICR mice with invasive pulmonary aspergillosis. Chin. Herb. Med. 11, 429-433. https://doi.org/10.1016/j.chmed.2019.09.004 (2019). Ali, E. M. & Abdallah, B. M. Effective Inhibition of Invasive Pulmonary Aspergillosis by Silver Nanoparticles Biosynthesized with Artemisia sieberi Leaf Extract. Nanomaterials. 12, 51. https://doi.org/10.3390/nano12010051 (2022). Abdallah, B. M. & Ali, E. M. Therapeutic Potential of Green Synthesized Gold Nanoparticles Using Extract of Leptadenia hastata against Invasive Pulmonary Aspergillosis. J. Fungi . 8, 442. https://doi.org/10.3390/jof8050442 (2022). Ali, E. M., Alfwuaires, M. A. & Badr, G. M. Therapeutic potential of Calotropis gigantea extract against invasive pulmonary aspergillosis: In vitro and in vivo study. Asian. Pac. J. Trop. Biomed . 12, 243-252 (2022). Hameed, M. et al . Formulation and Evaluation of a Clove Oil-Encapsulated Nanofiber Formulation for Effective Wound-Healing. Molecules . 26, 2491. https://doi.org/10.3390/molecules26092491 (2021). Batiha, G.E. et al. Syzygium aromaticum L. (Myrtaceae): Traditional Uses, Bioactive Chemical Constituents, Pharmacological and Toxicological Activities. Biomolecules. 10, 202. https://doi.org/10.3390/biom10020202 (2020). Sorour, S.S. et al . Anticoccidial and hepatoprotective effects of artemisinin liquid extract, cinnamon essential oil and clove essential oil against Eimeria stiedae infection in rabbits. Trop. Biomed. 35, 926-943 (2018). El-Hadary, A.E. & Ramadan Hassanien, M.F. Hepatoprotective effect of cold-pressed Syzygium aromaticum oil against carbon tetrachloride (CCl4)-induced hepatotoxicity in rats. Pharm. Biol. 54 , 1364-1372.http://dx.doi.org/10.3109/13880209.2015.1078381 (2016). Kazi, S., Abbasi, P. & Arain, A.A. Syzygium aromaticum: A potential hepatoprotective agent. J. Sheikh. Zayed. Med. Coll . 7 , 956-959. (2016). Gupta, R. & Sharma, A. Anti-hyperglycemic activity of aqueous extracts of some medicinal plants on wistar rats. J Diabetes Metab , 8 , 752. https://doi.org/10.4172/2155-6156.1000752 (2017). Tahir, H. U., Sarfraz, R. A., Ashraf, A., & Adil, S. Chemical Composition and Antidiabetic Activity of Essential Oils Obtained from Two Spices (Syzygium aromaticum and Cuminum cyminum). Int. J. Food Prop . 19, 2156-2164 https://doi.org/10.1080/10942912.2015.1110166 (2016). Bakour, M. et al . The Antioxidant Content and Protective Effect of Argan Oil and Syzygium aromaticum Essential Oil in Hydrogen Peroxide-Induced Biochemical and Histological Changes. Int. J. Mol. Sci. 19, 610. https://doi.org/10.3390/ijms19020610 (2018). Gülçin, İ., Elmastaş, M. & Aboul-Enein, H.Y. Antioxidant activity of clove oil–A powerful antioxidant source. Arab. J. Chem. 5 , 489-499. https://doi.org/10.1016/j.arabjc.2010.09.016 (2012). Soltani, M. et al . The Effects of Clove Oil on The Biochemical and Histological Parameters, and Autophagy Markers in Polycystic Ovary Syndrome-Model RatsInt . j. fertil. steril. 17, 187-194. https://doi.org/ 10.22074/ijfs.2022.543640.1260 (2023). Liu, B.B. et al . Essential oil of Syzygium aromaticum reverses the deficits of stress-induced behaviors and hippocampal p-ERK/p-CREB/brain-derived neurotrophic factor expression. Planta. Med. 81, 185-92. https://doi.org/10.1055/s-0034-1396150 (2015). Carrasco, F.R. et al . Immunomodulatory activity of Zingiber officinale Roscoe, Salvia officinalis L. and Syzygium aromaticum L. essential oils: evidence for humor- and cell-mediated responses. J. Pharm. Pharmacol . 61, 961-967. https://doi.org/10.1211/jpp.61.07.0017 (2009). Dibazar, S.P., Fateh, S. & Daneshmandi, S. Clove (Syzygium aromaticum) ingredients affect lymphocyte subtypes expansion and cytokine profile responses: An in vitro evaluation. J. Food. Drug. Anal. 22, 448-454. https://doi.org/10.1016/j.jfda.2014.04.005 (2014). Matsui, T. et al. Pulmonary aspergillosis in apparently healthy young rabbits. Vet. Pathol. 22, 200-205. https://doi.org/10.1177/030098588502200302 (1985). Additional Declarations No competing interests reported. Cite Share Download PDF Status: Published Journal Publication published 03 Jan, 2026 Read the published version in Scientific Reports → Version 1 posted Editorial decision: Revision requested 18 Nov, 2025 Reviews received at journal 15 Nov, 2025 Reviews received at journal 14 Nov, 2025 Reviews received at journal 12 Nov, 2025 Reviewers agreed at journal 08 Nov, 2025 Reviewers agreed at journal 08 Nov, 2025 Reviewers agreed at journal 07 Nov, 2025 Reviewers agreed at journal 06 Nov, 2025 Reviewers invited by journal 06 Nov, 2025 Editor assigned by journal 06 Nov, 2025 Editor invited by journal 06 Nov, 2025 Submission checks completed at journal 03 Nov, 2025 First submitted to journal 03 Nov, 2025 You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-7941551","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":545461078,"identity":"8f137f18-6118-4c16-994a-818077fa08e1","order_by":0,"name":"Sara Shokrpoor","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAAxUlEQVRIiWNgGAWjYDACCQZmCIO9AUKzEa+F5wBjA4laJBIYG4hyl/zs5sPGlTts5MxnvjF/wFBjx8AnfQC/FoM7x5ITz55JM5a5nWPYwHAsmYGNL4GAFokc44ONbYcTZ0iDtLAdYGDjIeSwGTAtkmeAWv4RoYXhRo5xIliLBI9hA2MbEVoMbqQlGzYC/SLBk1Y4I7EvmYcIhyUflmwEhpgE++ENHz58s5OT7yHkMBCAR0gCMEaJ0YCkZRSMglEwCkYBNgAA77g6reN0ljsAAAAASUVORK5CYII=","orcid":"","institution":"University of Tehran","correspondingAuthor":true,"prefix":"","firstName":"Sara","middleName":"","lastName":"Shokrpoor","suffix":""},{"id":545461079,"identity":"d46257ab-5837-4959-9fa6-b3a21dd85b2b","order_by":1,"name":"Mahya Lalehpoor","email":"","orcid":"","institution":"University of Tehran","correspondingAuthor":false,"prefix":"","firstName":"Mahya","middleName":"","lastName":"Lalehpoor","suffix":""},{"id":545461080,"identity":"4397079b-aced-4b81-9795-58d81632c5ca","order_by":2,"name":"Aghil Sharifzadeh","email":"","orcid":"","institution":"University of Tehran","correspondingAuthor":false,"prefix":"","firstName":"Aghil","middleName":"","lastName":"Sharifzadeh","suffix":""},{"id":545461081,"identity":"b69fa650-f0d9-4d1e-80c1-0f9300eb872c","order_by":3,"name":"Majid Masoudifard","email":"","orcid":"","institution":"University of Tehran","correspondingAuthor":false,"prefix":"","firstName":"Majid","middleName":"","lastName":"Masoudifard","suffix":""},{"id":545461082,"identity":"5241a82e-1dc1-4954-afe8-d202d73bfd2f","order_by":4,"name":"Farhang Sasani","email":"","orcid":"","institution":"University of Tehran","correspondingAuthor":false,"prefix":"","firstName":"Farhang","middleName":"","lastName":"Sasani","suffix":""},{"id":545461083,"identity":"f43f6da1-d9b7-4b36-afed-5dff5e1c98c4","order_by":5,"name":"Reihaneh Izadi Niaki","email":"","orcid":"","institution":"University of Tehran","correspondingAuthor":false,"prefix":"","firstName":"Reihaneh","middleName":"Izadi","lastName":"Niaki","suffix":""},{"id":545461084,"identity":"636c41d4-e93c-4586-b1f8-9e77726ac6aa","order_by":6,"name":"Ghazaleh Vazifehdoust","email":"","orcid":"","institution":"University of Tehran","correspondingAuthor":false,"prefix":"","firstName":"Ghazaleh","middleName":"","lastName":"Vazifehdoust","suffix":""}],"badges":[],"createdAt":"2025-10-25 13:57:41","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-7941551/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-7941551/v1","draftVersion":[],"editorialEvents":[{"content":"https://doi.org/10.1038/s41598-025-34405-5","type":"published","date":"2026-01-03T15:58:20+00:00"}],"editorialNote":"","failedWorkflow":false,"files":[{"id":96180763,"identity":"23ed7d55-9479-4815-b1e6-c4058379895c","added_by":"auto","created_at":"2025-11-18 12:34:06","extension":"docx","order_by":0,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":5443574,"visible":true,"origin":"","legend":"","description":"","filename":"Revised2PathologicEvaluationofSyzygiumaromaticumEssentialOilAgainstPulmonaryAspergillosisinNonneutropenicImmunosuppressedRabbits.docx","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/fe402f5f8dab082afd0713b3.docx"},{"id":96252530,"identity":"6b4c7fd1-ef5b-4f29-ae7d-bf2e316a2d55","added_by":"auto","created_at":"2025-11-19 07:41:07","extension":"jpg","order_by":2,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":317615,"visible":true,"origin":"","legend":"","description":"","filename":"Figure1.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/902690e1f74afa3993bf6f33.jpg"},{"id":96249957,"identity":"99670916-5515-49ff-948b-46ec1f83ed96","added_by":"auto","created_at":"2025-11-19 07:36:53","extension":"jpg","order_by":3,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":34928431,"visible":true,"origin":"","legend":"","description":"","filename":"Figure10.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/1c8eaaae82ff0f8b173a2efd.jpg"},{"id":96180759,"identity":"93bdfb13-59c8-4ccb-8fbb-29ade4f03128","added_by":"auto","created_at":"2025-11-18 12:34:06","extension":"jpg","order_by":4,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":108630,"visible":true,"origin":"","legend":"","description":"","filename":"Figure2.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/55a9686f4e33f1cf64b79384.jpg"},{"id":96250816,"identity":"1820cb88-3c59-48df-a6c1-eaeb6e728337","added_by":"auto","created_at":"2025-11-19 07:39:02","extension":"jpg","order_by":5,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":254604,"visible":true,"origin":"","legend":"","description":"","filename":"Figure3.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/cf52e450f9ba42a8d8d4ab34.jpg"},{"id":96251574,"identity":"080df69f-1cd8-4d71-b24c-61140f63d9ff","added_by":"auto","created_at":"2025-11-19 07:39:49","extension":"jpg","order_by":6,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":225673,"visible":true,"origin":"","legend":"","description":"","filename":"Figure4.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/bf3377eba0c27bc292c466fc.jpg"},{"id":96180773,"identity":"1e93486c-9abd-4239-b64b-4e227c74888f","added_by":"auto","created_at":"2025-11-18 12:34:06","extension":"jpg","order_by":7,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":17957297,"visible":true,"origin":"","legend":"","description":"","filename":"Figure5.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/c7e83e4d43c274ce0f128947.jpg"},{"id":96180777,"identity":"f2ed3307-962b-4320-8344-38cc7b9716fa","added_by":"auto","created_at":"2025-11-18 12:34:06","extension":"jpg","order_by":8,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":18022387,"visible":true,"origin":"","legend":"","description":"","filename":"Figure6.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/8881df31e9c1e143f61af166.jpg"},{"id":96252528,"identity":"55dc8d35-352e-4886-8695-a783ccdc78d0","added_by":"auto","created_at":"2025-11-19 07:41:07","extension":"jpg","order_by":9,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":16511547,"visible":true,"origin":"","legend":"","description":"","filename":"Figure7.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/a74d5dc7a66e2ac9325e0ddf.jpg"},{"id":96250910,"identity":"1cb68950-c5e9-40b4-b0cb-7aedaa68f31a","added_by":"auto","created_at":"2025-11-19 07:39:06","extension":"jpg","order_by":10,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":277561,"visible":true,"origin":"","legend":"","description":"","filename":"Figure8.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/ca9b36cb521d6ab351b1b099.jpg"},{"id":96180781,"identity":"528f0962-7f0b-4b4e-bb6d-d3cc7c8c3e28","added_by":"auto","created_at":"2025-11-18 12:34:06","extension":"jpg","order_by":11,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":34221154,"visible":true,"origin":"","legend":"","description":"","filename":"Figure9.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/12780ad7699b77a465c5c1f0.jpg"},{"id":96249636,"identity":"403dd904-d64e-4694-a9e5-6e91b256340e","added_by":"auto","created_at":"2025-11-19 07:35:47","extension":"json","order_by":12,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":9643,"visible":true,"origin":"","legend":"","description":"","filename":"f3c11e2da29044f08f5e002d0cfdfcc8.json","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/79997d9f6f5d3cc0ff6225e0.json"},{"id":96180767,"identity":"4ddb2666-475a-49d7-b54d-b164b6634811","added_by":"auto","created_at":"2025-11-18 12:34:06","extension":"xml","order_by":13,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":182235,"visible":true,"origin":"","legend":"","description":"","filename":"f3c11e2da29044f08f5e002d0cfdfcc81enriched.xml","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/06c3e00350be05ed867edebc.xml"},{"id":96180765,"identity":"5582b4e1-769b-48e8-b409-7fc4b210c807","added_by":"auto","created_at":"2025-11-18 12:34:06","extension":"jpg","order_by":14,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":317615,"visible":true,"origin":"","legend":"","description":"","filename":"Figure1.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/f45c215ec7e64bf1aa11f90b.jpg"},{"id":96180795,"identity":"3091442d-0b96-45d8-a814-bdd1b7db60bf","added_by":"auto","created_at":"2025-11-18 12:34:07","extension":"jpg","order_by":15,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":34928431,"visible":true,"origin":"","legend":"","description":"","filename":"Figure10.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/fc375770ba96576f7e79155e.jpg"},{"id":96180770,"identity":"50e46ba8-27d3-4713-968e-401c6fd35e9a","added_by":"auto","created_at":"2025-11-18 12:34:06","extension":"jpg","order_by":16,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":108630,"visible":true,"origin":"","legend":"","description":"","filename":"Figure2.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/d2fbf64ef07e61f7994f4f38.jpg"},{"id":96252607,"identity":"54a2dc1f-a74f-4fe4-9e57-fe866d84da86","added_by":"auto","created_at":"2025-11-19 07:41:16","extension":"jpg","order_by":17,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":254604,"visible":true,"origin":"","legend":"","description":"","filename":"Figure3.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/4f32d646949f86efa5416c49.jpg"},{"id":96252351,"identity":"8c5f7315-6839-46c8-8dac-dc19f396bd59","added_by":"auto","created_at":"2025-11-19 07:40:50","extension":"jpg","order_by":18,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":225673,"visible":true,"origin":"","legend":"","description":"","filename":"Figure4.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/e4e0184021c46f22a22a6127.jpg"},{"id":96250836,"identity":"497062c4-c52b-48b2-a3c6-c268db2553f8","added_by":"auto","created_at":"2025-11-19 07:39:03","extension":"jpg","order_by":19,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":17957297,"visible":true,"origin":"","legend":"","description":"","filename":"Figure5.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/7d6b9e8ee8c35f06e80f74ad.jpg"},{"id":96251552,"identity":"1852a9bd-3b5d-4939-8eaa-16f2aba4f213","added_by":"auto","created_at":"2025-11-19 07:39:48","extension":"jpg","order_by":20,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":18022387,"visible":true,"origin":"","legend":"","description":"","filename":"Figure6.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/7449738664c443cbabcc500e.jpg"},{"id":96252451,"identity":"44b9ee70-4389-4317-a9c1-091562357b26","added_by":"auto","created_at":"2025-11-19 07:40:58","extension":"jpg","order_by":21,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":16511547,"visible":true,"origin":"","legend":"","description":"","filename":"Figure7.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/36091137dd1c01203f479452.jpg"},{"id":96180785,"identity":"343f100f-60f5-4b34-9003-9319fb3cfb01","added_by":"auto","created_at":"2025-11-18 12:34:06","extension":"jpg","order_by":22,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":277561,"visible":true,"origin":"","legend":"","description":"","filename":"Figure8.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/e667d3dec4d46e13b4a75eec.jpg"},{"id":96252488,"identity":"d3b94705-006d-4ba5-a98b-8478b87141c5","added_by":"auto","created_at":"2025-11-19 07:41:02","extension":"jpg","order_by":23,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":34221154,"visible":true,"origin":"","legend":"","description":"","filename":"Figure9.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/eb04c4ecfa6bf494d09cc15f.jpg"},{"id":96180774,"identity":"e15daa22-f097-4b89-bed8-33c2029b8df0","added_by":"auto","created_at":"2025-11-18 12:34:06","extension":"png","order_by":24,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":49168,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage1.png","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/a361986f6d6d501ce268ffd3.png"},{"id":96251840,"identity":"456521cc-1cb6-4697-bf61-f0bf867761a6","added_by":"auto","created_at":"2025-11-19 07:40:08","extension":"jpeg","order_by":25,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":985658,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage10.jpeg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/d933d5d28b4f3025abc4cc8b.jpeg"},{"id":96180803,"identity":"fcf28f12-4906-4c41-966b-2840319cc1b4","added_by":"auto","created_at":"2025-11-18 12:34:07","extension":"jpeg","order_by":26,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":979070,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage11.jpeg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/2f7806c9d182c5ce813ecb20.jpeg"},{"id":96180775,"identity":"764e3af3-225e-4ff4-a9ae-728c756517a4","added_by":"auto","created_at":"2025-11-18 12:34:06","extension":"jpeg","order_by":27,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":317615,"visible":true,"origin":"","legend":"","description":"","filename":"Figure1.jpeg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/2c7f240246fb72415e5e04d7.jpeg"},{"id":96252372,"identity":"d486aab0-4b3d-4dfd-97af-00a9acfcb370","added_by":"auto","created_at":"2025-11-19 07:40:51","extension":"jpeg","order_by":28,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":68026,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage3.jpeg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/05c09f6a95763de0865993cc.jpeg"},{"id":96180780,"identity":"13f19194-b8dc-4d2b-a697-f5bddc9ead3a","added_by":"auto","created_at":"2025-11-18 12:34:06","extension":"jpeg","order_by":29,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":254604,"visible":true,"origin":"","legend":"","description":"","filename":"Figure3.jpeg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/0f489d71411b529df8a906a0.jpeg"},{"id":96180801,"identity":"ed2c1817-7cc2-457c-a51c-ba55bba78b1f","added_by":"auto","created_at":"2025-11-18 12:34:07","extension":"jpeg","order_by":30,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":122591,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage5.jpeg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/d0e3bc742168225e7a3bdc0f.jpeg"},{"id":96251903,"identity":"055d8f76-168a-4553-9b85-99b7d9c0220a","added_by":"auto","created_at":"2025-11-19 07:40:10","extension":"jpeg","order_by":31,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":794022,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage6.jpeg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/1583444e3f35d25b052211b0.jpeg"},{"id":96252027,"identity":"184a207a-7531-4eaa-a276-9a3c95164204","added_by":"auto","created_at":"2025-11-19 07:40:20","extension":"jpeg","order_by":32,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":808115,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage7.jpeg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/58345fc7ecd1935eba9c577c.jpeg"},{"id":96180812,"identity":"8c894251-2cfb-42dd-8050-cb02bc6b929c","added_by":"auto","created_at":"2025-11-18 12:34:07","extension":"jpeg","order_by":33,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":858971,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage8.jpeg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/5382599f5b85bcc999b8999c.jpeg"},{"id":96180790,"identity":"e020bdb8-7825-4024-944a-f5a5b6dcac21","added_by":"auto","created_at":"2025-11-18 12:34:06","extension":"jpeg","order_by":34,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":134533,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage9.jpeg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/050ba6396c7d512947e2f6f3.jpeg"},{"id":96180787,"identity":"a5e0a8f7-e5ab-4784-971a-c1d42e453059","added_by":"auto","created_at":"2025-11-18 12:34:06","extension":"png","order_by":35,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":220572,"visible":true,"origin":"","legend":"","description":"","filename":"OnlineFigure1.png","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/267ddec223fed8ddfa99208f.png"},{"id":96180822,"identity":"bd96a031-f73f-4629-aa45-37ab79f38ec5","added_by":"auto","created_at":"2025-11-18 12:34:08","extension":"png","order_by":36,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":12272982,"visible":true,"origin":"","legend":"","description":"","filename":"OnlineFigure10.png","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/153b31f4082001bedc1cb203.png"},{"id":96250833,"identity":"949a45fc-a675-454b-9ac2-a9a7e501ea7f","added_by":"auto","created_at":"2025-11-19 07:39:03","extension":"png","order_by":37,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":31125,"visible":true,"origin":"","legend":"","description":"","filename":"OnlineFigure2.png","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/a447f5a26ac8c4db233cc74f.png"},{"id":96251832,"identity":"910dce96-2da4-4a24-b894-c5be879b9176","added_by":"auto","created_at":"2025-11-19 07:40:06","extension":"png","order_by":38,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":831382,"visible":true,"origin":"","legend":"","description":"","filename":"OnlineFigure3.png","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/3e3b1a3104cb21228c2db930.png"},{"id":96180784,"identity":"0e5b9027-d22c-4349-b23b-7f700f6c54bc","added_by":"auto","created_at":"2025-11-18 12:34:06","extension":"png","order_by":39,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":79014,"visible":true,"origin":"","legend":"","description":"","filename":"OnlineFigure4.png","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/d3bbdd5fe60efde7e85528da.png"},{"id":96180818,"identity":"5f0deb62-bfb7-4287-b2df-37b4150ecf06","added_by":"auto","created_at":"2025-11-18 12:34:07","extension":"png","order_by":40,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":6554830,"visible":true,"origin":"","legend":"","description":"","filename":"OnlineFigure5.png","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/be0240ec8968ffcda6f9415a.png"},{"id":96250865,"identity":"d9b66376-3aa9-4e8b-99e2-a39a502ed882","added_by":"auto","created_at":"2025-11-19 07:39:04","extension":"png","order_by":41,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":6308062,"visible":true,"origin":"","legend":"","description":"","filename":"OnlineFigure6.png","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/89ed48bd15a829613b1c7c9c.png"},{"id":96252668,"identity":"5955e32a-a056-4a44-aecb-5521c8cff2c7","added_by":"auto","created_at":"2025-11-19 07:41:20","extension":"png","order_by":42,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":7336140,"visible":true,"origin":"","legend":"","description":"","filename":"OnlineFigure7.png","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/687c776aa59ba63e7f80b8e8.png"},{"id":96180799,"identity":"489cfc1a-e158-40d2-accb-d2e7e48ca73e","added_by":"auto","created_at":"2025-11-18 12:34:07","extension":"png","order_by":43,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":256181,"visible":true,"origin":"","legend":"","description":"","filename":"OnlineFigure8.png","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/cb34063c6345d0069672bd44.png"},{"id":96180816,"identity":"d02b870b-57a3-4f5c-aa82-b77990647286","added_by":"auto","created_at":"2025-11-18 12:34:07","extension":"png","order_by":44,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":13489093,"visible":true,"origin":"","legend":"","description":"","filename":"OnlineFigure9.png","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/b7291b5ac0e230e3eb526328.png"},{"id":96252533,"identity":"f1dbdaa0-5262-441f-a59b-f215ab395fff","added_by":"auto","created_at":"2025-11-19 07:41:07","extension":"png","order_by":45,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":25957,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage1.png","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/ecc0ab376083aab6b4b0e9aa.png"},{"id":96251915,"identity":"e49403ce-e9fb-409c-b627-847d830b0fd3","added_by":"auto","created_at":"2025-11-19 07:40:11","extension":"png","order_by":46,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":597858,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage10.png","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/8f323a93876444b632960a4e.png"},{"id":96249954,"identity":"6951b8b9-0a64-4ab4-8adc-586dc64b58b8","added_by":"auto","created_at":"2025-11-19 07:36:52","extension":"png","order_by":47,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":601378,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage11.png","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/2d61567f7e11927c2d1d0673.png"},{"id":96252263,"identity":"e19dcd05-65fb-488a-83d1-6b5cf1e91d3f","added_by":"auto","created_at":"2025-11-19 07:40:43","extension":"png","order_by":48,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":220572,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage2.png","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/48217c0e8ba7684c86da5897.png"},{"id":96180808,"identity":"621c26c3-4552-4257-8cf4-871212094571","added_by":"auto","created_at":"2025-11-18 12:34:07","extension":"png","order_by":49,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":15425,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage3.png","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/9897ef14c7b92e6adee5f347.png"},{"id":96251870,"identity":"ce5d615f-019c-4914-b2d5-a23446472255","added_by":"auto","created_at":"2025-11-19 07:40:09","extension":"png","order_by":50,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":831382,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage4.png","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/fe3422859b8516c887c971af.png"},{"id":96180800,"identity":"4ede4220-fe49-45b0-9a74-3627fec097b1","added_by":"auto","created_at":"2025-11-18 12:34:07","extension":"png","order_by":51,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":35559,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage5.png","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/2c13426c3a91e20de3e95917.png"},{"id":96252583,"identity":"6b4460c8-d10b-42a0-b29d-ce9cc379fad4","added_by":"auto","created_at":"2025-11-19 07:41:14","extension":"png","order_by":52,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":488159,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage6.png","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/2af83aa2fab6b7e49baa9afe.png"},{"id":96180805,"identity":"d7985e76-dcfa-4a6c-98ea-2d905df634aa","added_by":"auto","created_at":"2025-11-18 12:34:07","extension":"png","order_by":53,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":484016,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage7.png","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/b137bf3226368e6cab70ca43.png"},{"id":96180814,"identity":"7c9dfac2-2679-4922-8627-47e5272417b3","added_by":"auto","created_at":"2025-11-18 12:34:07","extension":"png","order_by":54,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":566711,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage8.png","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/879e7ceb1583923cf17d697e.png"},{"id":96252343,"identity":"edaf8a56-6947-441f-a8c2-9855ec6b293a","added_by":"auto","created_at":"2025-11-19 07:40:49","extension":"png","order_by":55,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":98003,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage9.png","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/e5645eaf8ffb6cf7616dd248.png"},{"id":96252060,"identity":"ebdd0d12-d7da-4267-9577-473e860dea53","added_by":"auto","created_at":"2025-11-19 07:40:24","extension":"xml","order_by":56,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":179460,"visible":true,"origin":"","legend":"","description":"","filename":"f3c11e2da29044f08f5e002d0cfdfcc81structuring.xml","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/950c0dfe93cbe38a1d506353.xml"},{"id":96180813,"identity":"641436d6-9a30-4ea1-847f-2a535c6f6d2f","added_by":"auto","created_at":"2025-11-18 12:34:07","extension":"html","order_by":57,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":197188,"visible":true,"origin":"","legend":"","description":"","filename":"earlyproof.html","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/7325b1e1adfff5f19b3ff3a8.html"},{"id":96180756,"identity":"5ea4d6e3-0e38-4b83-b5f1-88fa339b71a1","added_by":"auto","created_at":"2025-11-18 12:34:06","extension":"jpg","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":317615,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eA)\u003c/strong\u003e Clove essential oil MIC, \u003cstrong\u003eB)\u003c/strong\u003e Clove essential oil MFC, \u003cstrong\u003eC)\u003c/strong\u003eItraconazole MFC\u003c/p\u003e","description":"","filename":"Figure1.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/b1bdc839c0c2079af3085e1d.jpg"},{"id":96180755,"identity":"33248595-539b-4bd9-abc9-b8764dae30ec","added_by":"auto","created_at":"2025-11-18 12:34:06","extension":"jpg","order_by":2,"title":"Figure 2","display":"","copyAsset":false,"role":"figure","size":108630,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eA)\u003c/strong\u003e Clove essential oil Time-killing curve, \u003cstrong\u003eB)\u003c/strong\u003e Itraconazole Time-killing curve.\u003c/p\u003e","description":"","filename":"Figure2.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/6c7230d952b8000baf7bbf2c.jpg"},{"id":96180757,"identity":"06336d6a-bb2d-4ba7-aab6-494b5f916d36","added_by":"auto","created_at":"2025-11-18 12:34:06","extension":"jpg","order_by":3,"title":"Figure 3","display":"","copyAsset":false,"role":"figure","size":254604,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eCT scans on days 0, 7, and 13 post-inoculations with \u003c/strong\u003e\u003cem\u003e\u003cstrong\u003eAspergillus\u003c/strong\u003e\u003c/em\u003e\u003cstrong\u003e \u003c/strong\u003e\u003cem\u003e\u003cstrong\u003efumigatus\u003c/strong\u003e\u003c/em\u003e\u003cstrong\u003e \u003c/strong\u003e\u003cem\u003e\u003cstrong\u003eATCC\u003c/strong\u003e\u003c/em\u003e\u003cstrong\u003e \u003c/strong\u003e\u003cem\u003e\u003cstrong\u003e13073\u003c/strong\u003e\u003c/em\u003e\u003cstrong\u003e. \u003c/strong\u003eA) Day 0 and before fungal inoculation, 1) negative control group (normal saline), 2) positive control group (Itraconazole) 3) clove essential oil at 20 mg/kg 4) clove essential oil at 10 mg/kg B) Day 7 post-inoculation, 1) negative control group (normal saline), 2) positive control group (Itraconazole) 3) clove essential oil at 20 mg/kg 4) clove essential oil at 10 mg/kg C) Day 13 post-inoculation1) negative control group (normal saline), 2) positive control group (Itraconazole) 3) clove essential oil at 20 mg/kg 4) clove essential oil at 10 mg/kg. The arrow shows nodular lesions involved rabbits’ lungs.\u003c/p\u003e","description":"","filename":"Figure3.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/a7742d808e8f1f731de9aed9.jpg"},{"id":96180762,"identity":"a8526046-1400-4c7a-aa1d-a17de86c6a5b","added_by":"auto","created_at":"2025-11-18 12:34:06","extension":"jpg","order_by":4,"title":"Figure 4","display":"","copyAsset":false,"role":"figure","size":225673,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eA)\u003c/strong\u003e Mean lung weights between the study groups on days 7 and 13 bar chart, \u003cstrong\u003eB)\u003c/strong\u003e Fungal burden of BALF between the study groups on days 7 and 13 bar chart, \u003cstrong\u003eC) \u003c/strong\u003eFungal burden of lung tissue between the study groups on days 7 and 13 bar chart.\u003c/p\u003e","description":"","filename":"Figure4.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/dd0ee84c68863682ee83076d.jpg"},{"id":96251828,"identity":"15a793be-6f68-4c98-a2c1-7b10fd072bd4","added_by":"auto","created_at":"2025-11-19 07:40:06","extension":"jpg","order_by":5,"title":"Figure 5","display":"","copyAsset":false,"role":"figure","size":17957297,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eMacroscopic and microscopic figures of lung on 7-day post-inoculation to the \u003c/strong\u003e\u003cem\u003e\u003cstrong\u003eAspergillus\u003c/strong\u003e\u003c/em\u003e\u003cstrong\u003e \u003c/strong\u003e\u003cem\u003e\u003cstrong\u003efumigatus\u003c/strong\u003e\u003c/em\u003e\u003cstrong\u003e strain \u003c/strong\u003e\u003cem\u003e\u003cstrong\u003eATCC\u003c/strong\u003e\u003c/em\u003e\u003cstrong\u003e \u003c/strong\u003e\u003cem\u003e\u003cstrong\u003e13073\u003c/strong\u003e\u003c/em\u003e\u003cem\u003e. \u003c/em\u003eA) Negative control group (normal saline) 1) Macroscopic view of a rabbit lung\u003csup\u003e34\u003c/sup\u003e, 2) Extensive pulmonary involvement (star), H\u0026amp;E. 3) Accumulation of proteinaceous material and edema (star), H\u0026amp;E. 4) Multifocal necrosis (arrowheads) and scattered giant cell formation (arrow), H\u0026amp;E. B) Positive control group (Itraconazole) 1) Macroscopic view of a rabbit lung 2) Significant pulmonary involvement, H\u0026amp;E. 3) Alveolar atelectasia and mild pulmonary involvement , H\u0026amp;E. 4) Scattered giant cell formation (arrow), H\u0026amp;E.\u0026nbsp; C) Clove essential oil at 20 mg/kg 1) Macroscopic view of a rabbit lung 2) Extensive pulmonary involvement along with hemorrhage (star), H\u0026amp;E. 3) Accumulation of proteinaceous material and edema (star), H\u0026amp;E. 4) focal necrosis (arrowhead) and scattered giant cell formation (arrow), H\u0026amp;E. D) Clove essential oil at 10 mg/kg 1) Macroscopic view of a rabbit lung 2) Extensive pulmonary involvement H\u0026amp;E. 3) Multifocal necrosis (arrowheads) H\u0026amp;E. 4) Scattered giant cell formation (arrow), H\u0026amp;E.\u003c/p\u003e","description":"","filename":"Figure5.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/a607c484ecc87c21fdfd31d7.jpg"},{"id":96180796,"identity":"214623d6-38c9-430e-9dc6-7cb54e90bee7","added_by":"auto","created_at":"2025-11-18 12:34:07","extension":"jpg","order_by":6,"title":"Figure 6","display":"","copyAsset":false,"role":"figure","size":18022387,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eMacroscopic and microscopic Figures of lung on 13-day post-inoculation to the \u003c/strong\u003e\u003cem\u003e\u003cstrong\u003eAspergillus\u003c/strong\u003e\u003c/em\u003e\u003cstrong\u003e \u003c/strong\u003e\u003cem\u003e\u003cstrong\u003efumigatus\u003c/strong\u003e\u003c/em\u003e\u003cstrong\u003e strain \u003c/strong\u003e\u003cem\u003e\u003cstrong\u003eATCC\u003c/strong\u003e\u003c/em\u003e\u003cstrong\u003e \u003c/strong\u003e\u003cem\u003e\u003cstrong\u003e13073\u003c/strong\u003e\u003c/em\u003e\u003cem\u003e. \u003c/em\u003eA) Negative control group (normal saline) 1) Macroscopic view of rabbit lung\u003csup\u003e34\u003c/sup\u003e, 2) Extensive pulmonary involvement a long with pyogranulomas (arrowhead), H\u0026amp;E. 3) Accumulation of neutrophils within alveolar spaces (arrowheads), H\u0026amp;E. 4) Multifocal Splendore-Hoeppli phenomenon formation (arrow), H\u0026amp;E. B) Positive control group (Itraconazole) 1) Macroscopic view of rabbit lung 2) Focal pulmonary involvement (star) , H\u0026amp;E. 3) Focal pulmonary involvement and giant cell formation (arrowhead), H\u0026amp;E. 4) Multifocal Splendore-Hoeppli phenomenon formation (arrow), H\u0026amp;E. C) Clove essential oil at 20 mg/kg 1) Macroscopic view of rabbit lung 2) Focal pulmonary involvement (star), H\u0026amp;E. 3 Focal pulmonary involvement and Splendore-Hoeppli phenomenon formation (arrow), H\u0026amp;E. 4) Focal Splendore-Hoeppli phenomenon formation (arrow), H\u0026amp;E. D) Clove essential oil at 10 mg/kg 1) Macroscopic view of rabbit lung 2) Extensive pulmonary involvement accompanied by perivascular inflammation (arrowheads) H\u0026amp;E. 3) Alveolar atelectasis along with giant cell formation (arrowhead), H\u0026amp;E. 4) Numerous giant cell formations (arrows), H\u0026amp;E.\u003c/p\u003e","description":"","filename":"Figure6.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/2d1178840d3ff2bcf3217d6d.jpg"},{"id":96252051,"identity":"36d4b1f0-46e3-4abe-b33c-39a93557ce05","added_by":"auto","created_at":"2025-11-19 07:40:23","extension":"jpg","order_by":7,"title":"Figure 7","display":"","copyAsset":false,"role":"figure","size":16511547,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eHistochemistry and Immunohistochemistry examination of rabbits’ lungs on 13-day post-inoculation to the \u003c/strong\u003e\u003cem\u003e\u003cstrong\u003eAspergillus\u003c/strong\u003e\u003c/em\u003e\u003cstrong\u003e \u003c/strong\u003e\u003cem\u003e\u003cstrong\u003efumigatus\u003c/strong\u003e\u003c/em\u003e\u003cstrong\u003e strain \u003c/strong\u003e\u003cem\u003e\u003cstrong\u003eATCC\u003c/strong\u003e\u003c/em\u003e\u003cstrong\u003e \u003c/strong\u003e\u003cem\u003e\u003cstrong\u003e13073\u003c/strong\u003e\u003c/em\u003e\u003cem\u003e. \u003c/em\u003eA) Negative control group (normal saline) 1) The arrow shows fungal structure, GMS staining 2) Extensive pulmonary biomarker expression, CD68 marker. 3) Remarkable pulmonary biomarker expression, CD163 marker. 4) Extensive pulmonary biomarker expression, MPO marker. B) Positive control group (Itraconazole) 1) The arrow shows fungal structure, GMS staining 2) Low pulmonary biomarker expression, CD68 marker. 3) Insignificant pulmonary biomarker expression, CD163 marker. 4) Mild pulmonary biomarker expression, MPO marker C) Clove essential oil at 20 mg/kg 1) The arrow shows fungal structure, GMS staining. 2) Low pulmonary biomarker expression, CD68 marker. 3) Insignificant pulmonary biomarker expression, CD163 marker. 4) Mild pulmonary biomarker expression, MPO marker. D) Clove essential oil at 10 mg/kg 1) 1) The arrow shows fungal structure, GMS staining 2) Significant pulmonary biomarker expression, CD68 marker. 3) Moderate pulmonary biomarker expression, CD163 marker. 4) Relatively notable pulmonary biomarker expression, MPO marker.\u003c/p\u003e","description":"","filename":"Figure7.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/1ba00131cfceadd460ec8ba0.jpg"},{"id":96180764,"identity":"3c80361b-03b9-45ae-b865-ae9322b8b127","added_by":"auto","created_at":"2025-11-18 12:34:06","extension":"jpg","order_by":8,"title":"Figure 8","display":"","copyAsset":false,"role":"figure","size":277561,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eA)\u003c/strong\u003e Percentage of CD68 expression bar chart, B) Percentage of CD163 expression bar chart, C) Percentage of MPO expression bar chart, D) Percentage of pulmonary involvement bar chart.\u003c/p\u003e","description":"","filename":"Figure8.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/d03a35130998e99070f51442.jpg"},{"id":96180811,"identity":"27170165-d9d4-4d13-ab16-31644a729555","added_by":"auto","created_at":"2025-11-18 12:34:07","extension":"jpg","order_by":9,"title":"Figure 9","display":"","copyAsset":false,"role":"figure","size":34221154,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eHistopathological examination of vital organs after receiving treatments for 6 days. H\u0026amp;E. \u003c/strong\u003eA) Heart 1) Negative control group (normal saline) 2) Positive control group (Itraconazole) 3) Clove essential oil at 20 mg/kg 4) Clove essential oil at 10 mg/kg. B) Kidney 1) Negative control group (normal saline) 2) Positive control group (Itraconazole) 3) Clove essential oil at 20 mg/kg 4) Clove essential oil at 10 mg/kg. C) Liver 1) Negative control group (normal saline) 2) Positive control group (Itraconazole) 3) Clove essential oil at 20 mg/kg 4) Clove essential oil at 10 mg/kg. D) Spleen 1) Negative control group (normal saline) 2) Positive control group (Itraconazole) 3) Clove essential oil at 20 mg/kg 4) Clove essential oil at 10 mg/kg. E) Brain 1) Negative control group (normal saline) 2) Positive control group (Itraconazole) 3) Clove essential oil at 20 mg/kg 4) Clove essential oil at 10 mg/kg, H\u0026amp;E.\u003c/p\u003e","description":"","filename":"Figure9.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/2b7b7740b354f67e479fa75c.jpg"},{"id":96252370,"identity":"7d09131b-f9b8-47bf-8b2a-1b33087b8d2c","added_by":"auto","created_at":"2025-11-19 07:40:51","extension":"jpg","order_by":10,"title":"Figure 10","display":"","copyAsset":false,"role":"figure","size":34928431,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eHistopathological examination of vital organs after receiving treatments for 12 days. H\u0026amp;E. \u003c/strong\u003eA) Heart 1) Negative control group (normal saline) 2) Positive control group (Itraconazole) 3) Clove essential oil at 20 mg/kg 4) Clove essential oil at 10 mg/kg. B) Kidney 1) Negative control group (normal saline) 2) Positive control group (Itraconazole) 3) Clove essential oil at 20 mg/kg 4) Clove essential oil at 10 mg/kg. C) Liver 1) Negative control group (normal saline) 2) Positive control group (Itraconazole) 3) Clove essential oil at 20 mg/kg 4) Clove essential oil at 10 mg/kg. D) Spleen 1) Negative control group (normal saline) 2) Positive control group (Itraconazole) 3) Clove essential oil at 20 mg/kg 4) Clove essential oil at 10 mg/kg. E) Brain 1) Negative control group (normal saline) 2) Positive control group (Itraconazole) 3) Clove essential oil at 20 mg/kg 4) Clove essential oil at 10 mg/kg, H\u0026amp;E.\u003c/p\u003e","description":"","filename":"Figure10.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/c4abb221e7302c8643dfa1b0.jpg"},{"id":99545375,"identity":"f630a7f4-18a3-446d-ad34-691874e394db","added_by":"auto","created_at":"2026-01-05 16:06:42","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":124393919,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-7941551/v1/8f5a9e3a-40bc-49ac-a35d-c086472a7d4f.pdf"}],"financialInterests":"No competing interests reported.","formattedTitle":"Pathologic Evaluation of Syzygium aromaticum Essential Oil Against Pulmonary Aspergillosis in Non-neutropenic Immunosuppressed Rabbits","fulltext":[{"header":"Introduction","content":"\u003cp\u003e\u003cem\u003eAspergillus\u003c/em\u003e, a ubiquitous saprophytic fungus, is widely found in soil, building dust, and hospital environments\u003csup\u003e\u003cspan citationid=\"CR1\" class=\"CitationRef\"\u003e1\u003c/span\u003e\u003c/sup\u003e. \u003cem\u003eAspergillus fumigatus\u003c/em\u003e spores continually threaten the respiratory tract by inducing inflammatory responses predominantly mediated by macrophages and epithelial cells\u003csup\u003e\u003cspan citationid=\"CR2\" class=\"CitationRef\"\u003e2\u003c/span\u003e\u003c/sup\u003e. Pulmonary aspergillosis is generally classified into three broad categories: allergic bronchopulmonary aspergillosis, chronic pulmonary aspergillosis, and invasive pulmonary aspergillosis\u003csup\u003e\u003cspan citationid=\"CR1\" class=\"CitationRef\"\u003e1\u003c/span\u003e\u003c/sup\u003e. Invasive aspergillosis (IA) is recognized as a significant cause of morbidity and mortality in severely immunocompromised patients and primarily involves the lungs through inhalation of \u003cem\u003eAspergillus\u003c/em\u003e conidia\u003csup\u003e\u003cspan citationid=\"CR3\" class=\"CitationRef\"\u003e3\u003c/span\u003e\u003c/sup\u003e. Consequently, invasive pulmonary aspergillosis (IPA) is considered a serious and life-threatening infection in patients undergoing immunosuppressive therapies with severe and prolonged neutropenia, such as myelotoxic chemotherapy for cancer treatment\u003csup\u003e\u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e\u003c/sup\u003e. Invasive pulmonary aspergillosis progresses rapidly and has a high mortality rate of up to 50%\u003csup\u003e1\u003c/sup\u003e. The critical role of neutrophils in eliminating \u003cem\u003eAspergillus\u003c/em\u003e conidia has been proven\u003csup\u003e\u003cspan citationid=\"CR1\" class=\"CitationRef\"\u003e1\u003c/span\u003e,\u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e5\u003c/span\u003e\u003c/sup\u003e. Additionally, the efficacy of lysosomes in phagosomes and the acidification of phagosomes determine the capacity of airway epithelial cells to control \u003cem\u003eAspergillus fumigatus\u003c/em\u003e growth. Overall, the airway epithelium demonstrates greater ability to inhibit fungal survival in bronchial cells in comparison with alveolar cells, and specific cell wall mutants of \u003cem\u003eAspergillus fumigatus\u003c/em\u003e can affect phagosome maturation in epithelial cells\u003csup\u003e\u003cspan citationid=\"CR6\" class=\"CitationRef\"\u003e6\u003c/span\u003e\u003c/sup\u003e. Recent years have witnessed an increased incidence of invasive aspergillosis in non-neutropenic patients, including individuals with hematological malignancies undergoing chemotherapy, patients admitted to intensive care unit (ICU), and those treated with corticosteroids were reported\u003csup\u003e\u003cspan citationid=\"CR1\" class=\"CitationRef\"\u003e1\u003c/span\u003e,\u003cspan citationid=\"CR7\" class=\"CitationRef\"\u003e7\u003c/span\u003e\u003c/sup\u003e. It is estimated that only one-third of IPA cases are associated with long-term neutropenia\u003csup\u003e\u003cspan citationid=\"CR1\" class=\"CitationRef\"\u003e1\u003c/span\u003e\u003c/sup\u003e. Moreover, the emergence of COVID-19-associated pulmonary aspergillosis in ICU patients has further highlighted the importance of awareness regarding this pathogen\u003csup\u003e\u003cspan citationid=\"CR8\" class=\"CitationRef\"\u003e8\u003c/span\u003e\u003c/sup\u003e. Due to the clinical significance of this disease, extensive research is conducted annually on its pathophysiology, epidemiology, prognostic factors, and treatment methods\u003csup\u003e\u003cspan citationid=\"CR9\" class=\"CitationRef\"\u003e9\u003c/span\u003e,\u003cspan citationid=\"CR10\" class=\"CitationRef\"\u003e10\u003c/span\u003e\u003c/sup\u003e.\u003c/p\u003e\u003cp\u003eImmunosuppressive therapies, such as cyclosporine administration, are major predisposing factors for IPA\u003csup\u003e\u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e\u003c/sup\u003e. Cyclosporine, a potent immunosuppressant, is commonly used to prevent organ transplant rejection and manage autoimmune disorders\u003csup\u003e\u003cspan citationid=\"CR11\" class=\"CitationRef\"\u003e11\u003c/span\u003e\u003c/sup\u003e. It inhibits T-cell activation, which, while effective in preventing graft-versus-host disease, significantly impairs the immune system\u0026rsquo;s capacity to combat infections. As a result, patients receiving cyclosporine are at heightened risk for opportunistic infections, with \u003cem\u003eAspergillus\u003c/em\u003e representing one of the most prevalent and life-threatening pathogens\u003csup\u003e\u003cspan citationid=\"CR11\" class=\"CitationRef\"\u003e11\u003c/span\u003e\u003c/sup\u003e. Histopathological evaluation is a crucial tool for studying IPA, particularly for assessing lung tissue damage and disease progression in immunocompromised hosts. Examination of lung tissues under a light microscope allows the identification of pathological changes, including tissue necrosis, inflammation, and fungal hyphae presence all of which are indicative of \u003cem\u003eAspergillus\u003c/em\u003e invasion. Such analysis provides insights into fungal infection mechanisms and host responses, which are essential for developing effective diagnostic and therapeutic strategies\u003csup\u003e\u003cspan citationid=\"CR9\" class=\"CitationRef\"\u003e9\u003c/span\u003e,\u003cspan citationid=\"CR10\" class=\"CitationRef\"\u003e10\u003c/span\u003e\u003c/sup\u003e. Within ICU, the revised EORTC/MSG definitions categorize IPA in immunocompromised patients as proven, probable, or possible. Proven IPA requires histopathological confirmation of fungal invasion; probable IPA necessitates a combination of host factors, clinical signs, and positive mycological evidence, and possible IPA is identified by host factors and clinical signs but lacks mycological confirmation\u003csup\u003e\u003cspan citationid=\"CR12\" class=\"CitationRef\"\u003e12\u003c/span\u003e,\u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e13\u003c/span\u003e\u003c/sup\u003e.\u003c/p\u003e\u003cp\u003eMany clinically-used antifungal agents are associated with toxicity, drug\u0026ndash;drug interactions, lack of fungicidal effect, high cost, and emerging resistance among common fungal pathogens\u003csup\u003e\u003cspan citationid=\"CR14\" class=\"CitationRef\"\u003e14\u003c/span\u003e\u003c/sup\u003e. Therefore, extensive studies have been performed on \u003cem\u003eAspergillus\u003c/em\u003e both in vitro and in vivo\u003csup\u003e\u003cspan citationid=\"CR15\" class=\"CitationRef\"\u003e15\u003c/span\u003e\u003c/sup\u003e. Recent treatment recommendations have been updated emphasizing the combination of first line and second-line therapies, alongside the investigations into novel compounds\u003csup\u003e\u003cspan citationid=\"CR16\" class=\"CitationRef\"\u003e16\u003c/span\u003e\u003c/sup\u003e. Since \u003cem\u003eAspergillus\u003c/em\u003e species are well-known to be resistant to azole antifungal compounds, plant-derived essential oils and their major constituents have been evaluated for antifungal activity\u003csup\u003e\u003cspan citationid=\"CR17\" class=\"CitationRef\"\u003e17\u003c/span\u003e\u003c/sup\u003e. Clove plant (\u003cem\u003eSyzygium aromaticum\u003c/em\u003e), a member of the \u003cem\u003eMyrtaceae\u003c/em\u003e family, is globally among the most valued spices\u003csup\u003e\u003cspan citationid=\"CR18\" class=\"CitationRef\"\u003e18\u003c/span\u003e,\u003cspan citationid=\"CR19\" class=\"CitationRef\"\u003e19\u003c/span\u003e\u003c/sup\u003e. This plant contains eugenol, acetyl eugenol, beta-caryophyllene, vanillin, keratolic acid, tannins, and other compounds\u003csup\u003e\u003cspan citationid=\"CR19\" class=\"CitationRef\"\u003e19\u003c/span\u003e\u003c/sup\u003e. Eugenol, - a volatile, colorless to light-yellow, water-soluble phenylpropanoid with a strong odor and taste- constitutes the primary component of clove essential oil. It exhibits insecticidal, antimicrobial, and anti-inflammatory properties\u003csup\u003e\u003cspan citationid=\"CR20\" class=\"CitationRef\"\u003e20\u003c/span\u003e\u003c/sup\u003e and demonstrates potent antifungal activity against A. fumigatus in in vitro studies\u003csup\u003e\u003cspan citationid=\"CR14\" class=\"CitationRef\"\u003e14\u003c/span\u003e,\u003cspan citationid=\"CR17\" class=\"CitationRef\"\u003e17\u003c/span\u003e,\u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e21\u003c/span\u003e,\u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e22\u003c/span\u003e\u003c/sup\u003e. In addition to in vitro studies, the establishment of animal models of pulmonary aspergillosis and the design of preclinical studies to investigate antifungal are of great importance\u003csup\u003e\u003cspan citationid=\"CR15\" class=\"CitationRef\"\u003e15\u003c/span\u003e,\u003cspan citationid=\"CR23\" class=\"CitationRef\"\u003e23\u003c/span\u003e,\u003cspan citationid=\"CR24\" class=\"CitationRef\"\u003e24\u003c/span\u003e\u003c/sup\u003e. Rabbits in particular serve as valuable models due to their susceptibility to respiratory infections and similarities in immune response to humans\u003csup\u003e\u003cspan citationid=\"CR15\" class=\"CitationRef\"\u003e15\u003c/span\u003e, \u003cspan citationid=\"CR24\" class=\"CitationRef\"\u003e24\u003c/span\u003e, \u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e25\u003c/span\u003e\u003c/sup\u003e. Pulmonary lesions in immunosuppressed rabbits are classified into three categories: hemorrhagic infarction, neutrophilic, and monocytic lesions\u003csup\u003e\u003cspan citationid=\"CR24\" class=\"CitationRef\"\u003e24\u003c/span\u003e, \u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e25\u003c/span\u003e\u003c/sup\u003e. The use of cyclosporine\u0026ndash;methylprednisolone-treated rabbits simulate a non-neutropenic immunocompromised state, providing a relevant model for IPA studies\u003csup\u003e\u003cspan citationid=\"CR15\" class=\"CitationRef\"\u003e15\u003c/span\u003e\u003c/sup\u003e.\u003c/p\u003e\u003cp\u003eThis study aimed to establish an animal model of invasive pulmonary aspergillosis using standard non-neutropenic immunosuppression methods\u003csup\u003e\u003cspan citationid=\"CR15\" class=\"CitationRef\"\u003e15\u003c/span\u003e,\u003cspan citationid=\"CR24\" class=\"CitationRef\"\u003e24\u003c/span\u003e,\u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e\u003c/sup\u003e, and to evaluate the antifungal efficacy of clove essential oil in comparison with a conventional antifungal agent regarding in vitro and in vivo aspects. Therefore, the effects as well as therapeutic potency of clove essential oil at two different doses compared to Itraconazole in the direct exposure to fungus \u003cem\u003eAspergillus fumigatus ATCC 13073\u003c/em\u003e along with treatment of pulmonary aspergillosis in rabbits were investigated clinically, paraclinically, necropsy, mycologically and histopathologically.\u003c/p\u003e"},{"header":"Materials and Methods","content":"\u003cp\u003e\u003cstrong\u003eFungal Strain and Inoculum Preparation\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eA standard isolate of \u003cem\u003eAspergillus fumigatus\u003c/em\u003e (\u003cem\u003eATCC\u003c/em\u003e \u003cem\u003e13073\u003c/em\u003e) was used in this study. The cryopreserved stock culture was first thawed at room temperature. To activate the fungus, it was sub-cultured onto potato dextrose agar (PDA) plates and incubated at 28\u0026deg;C for 7 days to promote extensive sporulation and conidia formation\u003csup\u003e27,28\u003c/sup\u003e. The conidia were then harvested by gently flooding the agar surface with sterile saline containing 0.05% Tween 80. The resulting suspension was filtered through sterile gauze to remove hyphal fragments, and the conidial concentration was adjusted using a hemocytometer slide\u003csup\u003e28\u003c/sup\u003e.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eExtraction and Chemical Analysis of Essential Oil\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eClove essential oil was extracted from 100 grams of dried \u003cem\u003eSyzygium aromaticum\u003c/em\u003e (clove) powder via hydrodistillation for 4 hours using a Clevenger-type apparatus. The collected oil was dehydrated over anhydrous sodium sulfate and stored in an amber-glass vial at 4\u0026deg;C to protect it from light and oxidation until further use\u003csup\u003e19\u003c/sup\u003e.\u003c/p\u003e\n\u003cp\u003eThe chemical composition of the essential oil was characterized by gas chromatography\u0026ndash;mass spectrometry (GC\u0026ndash;MS). The analysis was performed using Thermoquest 2000. The chromatograph was equipped with Hp5 capillary column (30 \u0026times; 0.25 mmID\u0026times; 0.25 \u0026mu;m film thickness) and the data were acquired under the following conditions: initial temperature 50\u0026deg;C, program rate 2.5\u0026deg;C, final temperature 265\u0026deg;C and injector temperature 250\u0026deg;C. The carrier gas was helium at the flow rate of 1.1 ml/min, and the split ratio was 1:100. The essential oil was also analysed by GC mass spectrometry (GC/MS) on the same gas chromatograph coupled with MSD5973. The MS was run in the electron ionization mode, using ionization energy of 70 eV and interface temperature was 250\u0026deg;C. The components of essential oils were identified tentatively by comparing their retention indices and mass spectra with those of Wiley 275 Registry of Mass Spectral Data. The relative percentages of the constituents were calculated based on peak areas\u003csup\u003e19\u003c/sup\u003e.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eDetermination of Minimum Inhibitory and Fungicidal Concentrations (MIC/MFC)\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of clove essential oil against \u003cem\u003eAspergillus fumigatus\u003c/em\u003e (\u003cem\u003eATCC\u003c/em\u003e \u003cem\u003e13073\u003c/em\u003e) were determined according to the reference broth microdilution method\u003csup\u003e27\u003c/sup\u003e. The fungal strain was sub-cultured from a frozen stock onto Sabouraud dextrose agar (SDA) and incubated at 28\u0026deg;C for 5-7 days to promote conidiation. Conidia were harvested by adding 5 mL of sterile saline with 0.05% Tween 80 to the agar surface and gently scraping with a sterile loop. The resulting suspension was vortexed, and the conidial density was adjusted to a concentration of 4 \u0026times; 10⁴ CFU/mL in RPMI 1640 medium buffered with MOPS, as confirmed by hemocytometer count.\u0026nbsp;Two-fold serial dilutions of the clove essential oil were prepared in RPMI 1640 medium, yielding a concentration range of 0.02 to 20 \u0026mu;L/mL. Aliquots of 100 \u0026mu;L of each dilution were dispensed into the wells of a sterile 96-well microtiter plate. An equal volume (100 \u0026mu;L) of the standardized conidial inoculum was then added to each well. The plate was incubated at 35\u0026deg;C for 48 hours. The MIC was defined as the lowest essential oil concentration that resulted in the complete absence of visible fungal growth.\u0026nbsp;Following the incubation period, 100 \u0026mu;L from each well that showed no visible growth was sub-cultured onto fresh SDA plates. The plates were incubated at 35\u0026deg;C for 48 hours. The MFC was defined as the lowest essential oil concentration that resulted in either no growth or fewer than three colonies on the SDA plate, corresponding to a \u0026ge;99.9% reduction in the original inoculum viability, indicating a fungicidal effect. Concentrations that inhibited growth in the broth but did not meet this criterion upon sub-culturing were considered fungistatic.\u003csup\u003e27\u003c/sup\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTime-Kill Kinetics Assay\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe fungicidal kinetics of \u003cem\u003eSyzygium aromaticum\u003c/em\u003e essential oil (Clove EO) and itraconazole against \u003cem\u003eAspergillus fumigatus\u003c/em\u003e (\u003cem\u003eATCC\u003c/em\u003e \u003cem\u003e13073\u003c/em\u003e) were evaluated using a time-kill assay according to established methodologies with modifications. A conidial suspension was prepared from a 7-day-old culture grown on Sabouraud Dextrose Agar (SDA) at 28\u0026deg;C. The conidia were harvested by flooding the plate with sterile saline containing 0.05% Tween 80 and gently scraping the surface with a sterile loop. The suspension was adjusted to a final concentration of 4 \u0026times; 10⁵ CFU/mL in RPMI 1640 medium buffered with MOPS (0.165 M, pH 7.0) using a hemocytometer for quantification. The assay was performed by incubating the conidial suspension with Clove EO and itraconazole at multiple concentrations (e.g., 0.25x, 0.5x and 2x, the Minimum Inhibitory Concentration). A drug-free tube containing only the inoculum in RPMI 1640 medium served as a growth control. All tubes were incubated in a shaking incubator at 35\u0026deg;C. At predetermined time intervals (0, 2, 4, 8, 12, 16, 20, and 24 hours), 100 \u0026mu;L aliquots were removed from each tube. These aliquots were subjected to the fungicidal activity was defined as a \u0026ge;99.9% (or a 3-log10) reduction in the CFU/mL compared to the starting inoculum. Time-kill curves were generated by plotting the log10 CFU/mL against time.\u003csup\u003e28\u003c/sup\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAnimals\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eA total of 24 female New Zealand White rabbits, weighing 1.5\u0026ndash;2.5 kg, were obtained. The rabbits were acclimated for at least one week prior to the commencement of the study. The room temperature was maintained at 21 \u0026plusmn; 0.5\u0026deg;C with a 12-hour light/dark cycle, and the relative humidity was set at 45%. The animals had access to water and standard rabbit chows. In the current study, all experimental procedures and methods were conducted in accordance with the guidelines of the I.R Iran Ethics Committee for Research on working with Laboratory Animals (ID: IR.UT.VETMED.REC.1401.013) and the ARRIVE guidelines.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eEstablishment of the Non-neutropenic Immunosuppressed Animal Model of Invasive Pulmonary Aspergillosis\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eTo establish the animal model, New Zealand white rabbits received cyclosporine (CsA) at a dose of 10 mg/kg/day (0.5 mg/kg during 15 seconds), and methylprednisolone at a dose of 5 mg/kg/day intravenously for 14 consecutive days to induce immunosuppression without neutropenia.\u003csup\u003e25,26, 29\u003c/sup\u003e On the fourth day of the experiment, the fungal inoculum was delivered endotracheally under general anesthesia with ketamine and xylazine.\u003csup\u003e25, 26, 29, 30\u003c/sup\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMicroorganism and Conidial Suspension\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eTo prepare the inoculum, \u003cem\u003eAspergillus\u003c/em\u003e \u003cem\u003efumigatus\u003c/em\u003e strain \u003cem\u003eATCC\u003c/em\u003e \u003cem\u003e13073\u003c/em\u003e from a frozen isolate was subcultured onto Sabouraud dextrose agar (SDA) and incubated at 37\u0026deg;C until sufficient conidiation was achieved. Subsequently, 5 ml of sterile normal saline containing 0.05% Tween 20 was added to the culture medium under a laminar flow hood. The \u003cem\u003eAspergillus\u003c/em\u003e \u003cem\u003efumigatus\u003c/em\u003e strain \u003cem\u003eATCC\u003c/em\u003e \u003cem\u003e13073\u003c/em\u003e grown on the medium was gently scraped using a sterile culture loop, and the resulting suspension was collected with a Pasteur pipette. The desired concentration, 1 \u0026times; 10\u003csup\u003e8\u003c/sup\u003e to 1.25 \u0026times; 10\u003csup\u003e8\u003c/sup\u003e conidia in a volume of 250 to 350 \u0026mu;l, was adjusted using a hemocytometer slide and serial dilution.\u003csup\u003e4,26\u003c/sup\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAntifungal Treatment\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe rabbits were randomly assigned to four groups: negative control (n = 6), positive control (n = 6), treatment group A (n = 6), and treatment group B (n = 6). Antifungal treatment commenced 24 hours after fungal inoculation and continued until day 12. The negative control group received normal saline at 2 ml/kg, the positive control group received itraconazole at 30 mg/kg, treatment group A received clove essential oil at 10 mg/kg, and treatment group B received clove essential oil at 20 mg/kg. All treatments were administered orally every 24 hours using a syringe, slowly from the side of the mouth.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMonitoring and Evaluating Variables\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThroughout the study, the rabbits were monitored for survival time, as well as the status and extent of lung involvement in living animals. Post-mortem evaluations included the assessment of pulmonary macroscopic lesions, pulmonary and BALF fungal burden, and the presence or absence of systemic cytotoxicity in other vital organs.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eDaily Monitoring\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe rabbits were assessed daily for pain and welfare and were monitored for survival until day 13 post-inoculation (24 hours after the final treatment). The rabbit physiognomy scale was employed to evaluate features such as the shape of the nostrils, flattening of the cheeks, position and configuration of the ears, closure of the eyes, and changes in the whiskers and sensitive facial hair. General indicators of pain and distress, including darkening of the nails and feet, pallor of the eyes, closure of the third eyelid, and failure to assume a normal posture, were also recorded.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eComputing Tomography (CT) scan\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;CT images were acquired using a 2-slice CT scanner with the protocol of a slice thickness of 1-2 mm, a pitch of 0.9, and an ultra-sharp reconstruction Kernel (U90s) in the lung window. Scans were performed on days 0, 7, and 13 post-inoculations on one rabbit from each group under general anesthesia using ketamine and xylazine\u003csup\u003e29, 30\u003c/sup\u003e. The animals were positioned in sternal recumbency, and images were obtained in both sagittal and frontal planes.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePost-Mortem Analysis\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eOn days 7 and 13 post-inoculation, the animals were euthanized under deep anesthesia via intravenous administration of pentobarbital sodium (60\u0026ndash;100 mg/kg) and systematically necropsied to be used for samples and histopathological examination of the lungs as well as other vital organs\u003csup\u003e30\u003c/sup\u003e.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMacroscopic (Gross) Examination\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe lungs were examined for appearance changes, including hyperemia, hemorrhage, tissue consistency, and color. Other vital organs, including the heart, brain, kidneys, liver, and spleen, were inspected for indicators of systemic toxicity.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eWeighing the Lung tissue\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe net lung weight of each rabbit was carefully measured and recorded\u003csup\u003e26\u003c/sup\u003e.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eBALF Fungal Burden\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eBALF was collected from each lung for cytological examination and fungal culture. For this purpose, 10 ml of sterile normal saline was instilled into the lung via the trachea using a 12 ml sterile syringe, repeated twice. The lavage fluid was collected and centrifuged at 400 \u0026times; g for 10 minutes. The supernatant was discarded, and 2 ml of the pellet was retained. The remaining fluid was vortexed and aliquoted into 100 microliter volumes. 100 microliters of the obtained liquid were mounted on a slide and examined microscopically for the presence or the absence of fungal hyphae. In addition, 100 microliters of a 10⁻\u0026sup1; dilution was cultured on Sabouraud dextrose agar (SDA). The number of \u003cem\u003eAspergillus\u003c/em\u003e \u003cem\u003efumigatus\u003c/em\u003e colony-forming units in BALF was subsequently enumerated, and CFU/mL was calculated\u003csup\u003e26\u003c/sup\u003e.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eLung Fungal Burden\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eTo assess fungal burden, a defined portion of tissue was excised from each lung lobe and weighed in the next step. The tissue was then placed in a sterile container and homogenized with sterile normal saline for 30 seconds. dilutions of the homogenized lung (10⁻\u0026sup1; and 10⁻\u0026sup2;) were prepared in sterile normal saline. 100 microliters were then plated on Sabouraud dextrose agar (SDA) and incubated at 37 \u0026deg;C for 24 hours, followed by an additional 24 hur at room temperature. The number of \u003cem\u003eAspergillus\u003c/em\u003e \u003cem\u003efumigatus\u003c/em\u003e colony-forming units (CFU) in each lung lobe was subsequently enumerated, and CFU/g of tissue was calculated\u003csup\u003e26\u003c/sup\u003e.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eHistopathological Examination\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe remaining lung tissue was fixed in 10% neutral-buffered formalin for 24-48 hours for histopathological evaluation. Tissue processing was then performed using an automatic tissue processor, and paraffin-embedded tissue blocks were prepared by means of a paraffin dispenser. The tissue sections, with a thickness of 5\u0026mu;m, were then stained with the routine Harris Hematoxylin-Eosin stain\u003csup\u003e31\u003c/sup\u003e. Paraffin-embedded lung samples were further subjected to Gomori methenamine silver (GMS) staining to confirm fungal infection and associated inflammatory responses. Microscopically, pulmonary lesions were assessed for the presence and extent of hemorrhage, hyperemia, necrosis, thrombosis, infiltration and accumulation of inflammatory cells in bronchi, bronchioles, and alveoli, as well as for evidence of vascular fungal invasion. Also, to investigate the composition of inflammatory cells, by using CD68 and CD163 markers for M1 and M2 macrophages, respectively, and MPO (myeloperoxidase) marker for neutrophils, after blocking endogenous peroxidase with H2O2 solution and antigen retrieval with sodium citrate solution at pH=6 and by thermal method, immunohistochemistry was used\u003csup\u003e32\u003c/sup\u003e.\u003c/p\u003e\n\u003cp\u003eThe stained sections were examined under a light microscope, and micrographs were captured using a camera. Quantitative analysis of inflammatory cell distribution was performed with ImageJ software. Similarly, to examine the systemic cytotoxic status, sampling of other tissue components such as heart, liver, kidney, spleen and brain was performed. After fixation in 10% neutral buffered formalin, routine hematoxylin-eosin staining slides were prepared and examined for histopathological toxicological criteria under the light microscope\u003csup\u003e31\u003c/sup\u003e.\u0026nbsp;Finally, the study is in accordance with ARRIVE guidelines\u003csup\u003e33\u003c/sup\u003e.\u0026nbsp;\u003c/p\u003e"},{"header":"Results","content":"\u003cp\u003e\u003cstrong\u003e\u003cem\u003ein vitro\u003c/em\u003e\u003c/strong\u003e\u003cstrong\u003e\u0026nbsp;Study\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eGC\u0026ndash;MS Analysis\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe GC-MS analysis determined the following components, Table 1. Eugenol was the major component in studied clove essential oil with 96.81%.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp; \u003cstrong\u003eTable 1.\u003c/strong\u003e demonstrates most components of clove essential oil used in the study.\u003cimg src=\"https://myfiles.space/user_files/58895_8739fc6c57c1c19a/58895_custom_files/img1763465632.png\" alt=\"image\" width=\"839\" height=\"446\"\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMIC and MFC Determination\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;MIC and MFC of clove essential oil were 156.25 ppm and 625 ppm, respectively (Fig. 1 A and B). The MIC of Itraconazole was also determined to be 1 \u0026mu;g/mL (Fig. 1 C).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTime-Kill Kinetics\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe time-kill kinetics of clove essential oil and itraconazole were evaluated against \u003cem\u003eAspergillus fumigatus\u003c/em\u003e at concentrations of 2\u0026times;MIC, MIC, \u0026frac12;\u0026times;MIC, and \u0026frac14;\u0026times;MIC. Both agents exhibited a concentration-dependent fungicidal effect. A pronounced reduction in fungal viability, achieving up to a 2-log10 decrease in colony-forming units (CFU)/mL compared to the growth control, occurred within the first 4 to 12 hours of exposure.\u003c/p\u003e\n\u003cp\u003eThis initial rapid kill phase was followed by a period of relative stability in the fungal burden from 12 to 24 hours. Although a continued decline in CFU/mL was observed at the 2\u0026times;MIC and MIC concentrations during this later phase, the reduction did not constitute an additional logarithmic kill (i.e., a further 99% reduction). These data demonstrate that the primary fungicidal activity of both clove oil and itraconazole under these conditions occurs within the first 12 hours of exposure (Fig. 2).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cem\u003ein vivo\u003c/em\u003e\u003c/strong\u003e\u003cstrong\u003e\u0026nbsp;Study Results\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCT scan\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eCT scans were performed on days 0, 7, and 13 post-inoculations with \u003cem\u003eAspergillus\u003c/em\u003e \u003cem\u003efumigatus\u003c/em\u003e \u003cem\u003eATCC\u003c/em\u003e \u003cem\u003e13073\u003c/em\u003e. In the negative control group (normal saline), CT images revealed significant development and progression of nodular pulmonary lesions on days 7 and 13 compared with day 0. Between days 7 and 13, the extent of pulmonary involvement increased further. In contrast, rabbits in the positive control group (Itraconazole) exhibited fewer pulmonary lesions on day 7 post-inoculation than those in the negative control group. Following antifungal treatment, these rabbits demonstrated a favorable response to the treatment, with a reduction in patchy attenuation within the lung parenchyma between days 7 and 13. Rabbits treated with clove essential oil also showed fewer pulmonary lesions on day 7 compared with the negative control group. The higher dose (20 mg/kg) was associated with fewer lesions than the lower dose (10 mg/kg). Between days 7 and 13, lung lobe involvement in the clove-treated groups remained largely stable. Despite evident reductions in patchy attenuation and nodular pneumonia, the lesions demonstrated minimal progression, with signs of ongoing healing and a subtle decrease in lesion density. Overall, a minor difference in treatment response was observed between rabbits receiving Itraconazole and those treated with clove essential oil at 20 mg/kg on day 7. No statistically significant difference was observed between the two groups at this time point. However, by day 13 post-inoculation, the positive control group (Itraconazole) displayed a faster and better recovery (Fig. 3).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMacroscopic Examination for Cytotoxicity\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eMacroscopic evaluation of vital organs, including the heart, kidneys, liver, spleen, and brain, following the administration of normal saline, Itraconazole, and clove essential oil at the studied doses, revealed no significant differences in lesions or signs of systemic cytotoxicity. All examined tissues exhibited normal histological structure.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMacroscopic examination of the lung\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eMacroscopic examination of lung tissue in rabbits from different groups on days 7 and 13 post inoculation to \u003cem\u003eAspergillus\u003c/em\u003e \u003cem\u003efumigatus\u003c/em\u003e strain \u003cem\u003eATCC 13073\u003c/em\u003e, demonstrated a significant involvement of the lung lobes on day 7 in the form of small dark red hemorrhagic areas of varying sizes, the formation of nodules indicating an inflammatory response a variety of dark red spotted lesions, along with firm, aggregated, or confluent gray-to-white nodular lesions. Additionally, Fewer firm, flattened, confluent gray-to-red lesions were scattered throughout the lungs. \u0026nbsp;On day 13 post inoculation to the fungus, nodules indicating an inflammatory response were formed. These were firm, confluent, flattened gray-to-red lesions, and less firm, aggregated, or confluent gray-to-white nodules and areas of hemorrhage. An increase was shown in the extent of pulmonary involvement in the negative control group (normal saline). In contrast, concerning the groups treated with Itraconazole and clove essential oil at doses of 20 mg/kg and 10 mg/kg, respectively, the extent of pulmonary involvement either decreased on day 13 post-inoculation or the extent of lesions did not progress.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eComparison of mean lung weights between the study groups on days 7 and 13\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe results revealed a significant difference between the mean lung weights of the rabbits in the study groups, regardless of time. Tukey\u0026apos;s post hoc comparisons indicated that the mean lung weights in the Itraconazole group were significantly lower than those in the negative control group and the group treated with clove essential oil at a dose of 10 mg/kg (p\u0026lt;0.05). However, no significant difference was observed between the mean lung weights in this group compared to the clove essential oil group at a dose of 20 mg/kg (p\u0026gt;0.05). Likewise, no significant difference was observed between the mean lung weights of the other groups (p\u0026gt;0.05). Regarding time, there was also no significant difference between the average lung weights of rabbits on days 7 and 13 post-inoculation, regardless of group (p\u0026gt;0.05). (Fig. 4 A)\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eFungal burden of BALF and lung tissue\u003c/strong\u003e \u003cstrong\u003ebetween the study groups on days 7 and 13\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe analysis of the mean logarithm of fungal burden in the bronchoalveolar lavage fluid of the groups indicated a significant difference between the groups, regardless of time (p\u0026lt;0.05). Tukey\u0026apos;s post hoc comparisons showed that the mean logarithm of BALF fungal burden in the Itraconazole group was substantially lower than that to the negative control group (p \u0026lt; 0.05). Still, there was no significant difference between the means of these groups compared to the other groups (p \u0026gt; 0.05). Furthermore, comparing the mean logarithm of BALF fungal burden at different times (irrespective of the treatment group), indicated no significant differences between days 7 and 13 post inoculation (p\u0026gt;0.05). (Fig. 4 B)\u003c/p\u003e\n\u003cp\u003eRegarding the comparison of the mean logarithm of fungal burden of the rabbit lung of the studied groups, the results showed that there was a significant difference between them regardless of time (p\u0026lt;0.001). Tukey\u0026apos;s post hoc comparisons showed that the mean logarithm of lung fungal burden in the Itraconazole group was significantly lower compared to the other groups (p\u0026lt;0.05). Still, there was no significant difference between the mean logarithm of lung fungal burden in the other groups compared to each other (p\u0026gt;0.05). Also, by comparing the mean logarithm of lung fungal burden at different times (regardless of group), it was observed no significant difference between days 7 and 13 post-inoculation (p\u0026gt;0.05). (Fig. 4 C)\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eHistopathological examination of lung tissue\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eHistopathological examination of various lung lobes of the rabbits studied, including the left lung lobes (anterior and posterior) and the right lung lobes (anterior, middle, posterior and accessory) was performed at two-time intervals of 7- and 13-days post-inoculation to the \u003cem\u003eAspergillus\u003c/em\u003e \u003cem\u003efumigatus\u003c/em\u003e strain \u003cem\u003eATCC\u003c/em\u003e \u003cem\u003e13073\u003c/em\u003e. In order to assess the extent of lung tissue involvement, inflammatory response and other pathological lesions with three criteria of severe, moderate and mild and to calculate the percentage of lung lobe involvement compared to the typical structure of rabbit lung tissue, indicated that the infiltration of inflammatory cells comprised a significant number of neutrophils (heterophiles) and a smaller number of foamy alveolar macrophages, necrosis and cellular debris (necrotizing pneumonia), focal hemorrhage, edema, fibrin deposition, Langhans giant cells, infiltration of lymphocytes and the formation of asteroid bodies to a small extent in the samples corresponding to the seventh day after exposure. Exposure to \u003cem\u003eAspergillus\u003c/em\u003e \u003cem\u003efumigatus\u003c/em\u003e strain \u003cem\u003eATCC\u003c/em\u003e \u003cem\u003e13073\u003c/em\u003e, indicative of an acute to subacute inflammatory phase, was evident. The comparison of the above findings among the samples related to each group indicated that the highest level of involvement and pathological lung lesions was among rabbits in the negative control group without effective treatment (normal saline). In contrast, the positive control group (with itraconazole) showed the lowest level of lung involvement and pathological lesions caused by induced fungal infection and the inflammatory response associated with it. It is worth noting that in the groups treated with clove essential oil, the extent of lesions and inflammatory response in the lung tissue was lower in rabbits receiving a dose of 20 mg/kg compared to the dose of 10 mg/kg. (Fig. 5)\u003c/p\u003e\n\u003cp\u003eIn the examination of samples from day 13 after exposure to \u003cem\u003eAspergillus\u003c/em\u003e \u003cem\u003efumigatus\u003c/em\u003e strain \u003cem\u003eATCC\u003c/em\u003e \u003cem\u003e13073\u003c/em\u003e, a shift in the proportion of inflammatory cells was observed with an increase in the number of macrophages along with the formation of Langhans giant cells and numerous foreign bodies, infiltration of neutrophils, lymphoplasmacytic bronchiolitis, necrotic areas and cellular debris, hyperplasia of type II pneumocytes and the formation of abundant asteroid bodies consisting of small hyphae and ungerminated conidia of the fungus surrounded by inflammatory cells of neutrophils and epithelioid macrophages and deposition of amorphous eosinophilic protein materials in a radial and spheroidal arrangement indicating the onset of a chronic inflammatory response and a pyogranulomatous inflammatory reaction. In comparison between the studied groups, lung lesions and inflammatory response in rabbits in the negative control group without effective treatment (normal saline) showed the highest levels, and with time, the progression of pathological lesions due to the inflammatory response to the induced fungal infection was evident. The positive control group (with itraconazole) had the lowest involvement in lung tissue, and with time and drug administration, the severity of lung lesions decreased from day 7 to 13. In the groups receiving clove essential oil, the involvement of lung tissue at a dose of 20 mg/kg was generally less than that at a dose of 10 mg/kg, and the effects of improvement and reduction of inflammatory response from day 7 to 13 at a dose of 20 mg/kg were significantly greater than those at a dose of 10 mg/kg. (Fig. 6)\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eHistochemistry and Immunohistochemistry examination of lungs\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe presence of fungal structures scattered within rabbits\u0026rsquo; lungs and related inflammatory responses was confirmed by using GMS staining. Examination of the expression of the CD68 marker associated with M1 macrophages in lung samples on day 13 after exposure to \u003cem\u003eAspergillus\u003c/em\u003e \u003cem\u003efumigatus\u003c/em\u003e strain \u003cem\u003eATCC\u003c/em\u003e \u003cem\u003e13073\u003c/em\u003e in the studied groups showed that the normal saline group had higher expressions compared to other groups due to the severe inflammatory response to the fungus. After that, the clove essential oil group at a dose of 10 mg/kg had significant marker expression, while the itraconazole and clove essential oil groups at a dose of 20 mg/kg had the lowest levels, respectively.\u003c/p\u003e\n\u003cp\u003eExamination of the expression of the CD163 marker associated with M2 macrophages in lung samples on day 13 after exposure to \u003cem\u003eAspergillus\u003c/em\u003e \u003cem\u003efumigatus\u003c/em\u003e strain \u003cem\u003eATCC\u003c/em\u003e \u003cem\u003e13073\u003c/em\u003e in the studied groups showed that in the normal saline group, due to greater fungal contamination and the effect of Aspergillus fumigatus on the differentiation of M1 to M2 macrophages, the expression of the marker was higher than in the other groups, and in the itraconazole and clove essential oil groups at doses of 20 mg/kg and 10 mg/kg, respectively, it was lower.\u003c/p\u003e\n\u003cp\u003eExamination of the expression of MPO marker as an indicator for neutrophil differentiation in lung samples on day 13 after exposure to \u003cem\u003eAspergillus\u003c/em\u003e \u003cem\u003efumigatus\u003c/em\u003e strain \u003cem\u003eATCC\u003c/em\u003e \u003cem\u003e13073\u003c/em\u003e in the studied groups showed that the marker expression was lower in the itraconazole group as well as the clove essential oil group at a dose of 20 mg/kg than in the other groups. However, no notable changes were observed between the normal saline and clove essential oil groups at a dose of 10 mg/kg\u003cstrong\u003e\u0026nbsp;\u003c/strong\u003e(Fig. 7).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eComparison of lung lesions between the study groups on days 7 and 13\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eFigure shows the extent of lung involvement as determined by histopathology and macrophages type 1 and 2 and neutrophils specific markers in the control and clove essential oil-treated groups on days 7 and 13 post inoculation. Overall, Tukey\u0026apos;s post-hoc comparisons revealed that pulmonary lesions in rabbits being treated with Itraconazole were significantly less compared to those in the negative control group (without effective treatment) and the clove essential oil-treated group at a dose of 10 mg/kg (p\u0026lt;0.05). However, no significant differences were observed in the pulmonary lesions of rabbits in this group compared to the clove essential oil-treated group at a dose of 20 mg/kg (p\u0026gt;0.05). Additionally, no significant differences were detected between the pulmonary lesions in other groups (p\u0026gt;0.05). Regarding time, there was no significant difference between the pulmonary lesions of rabbits on days 7 and 13 post inoculation, regardless of treatment group (p\u0026gt;0.05) (Fig. 8).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMicroscopic examination of other tissue components\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eMicroscopic examination of the heart, kidney, liver, spleen, and brain of rabbits treated with clove essential oil at the studied doses (including two doses of 10 and 20 mg/kg),\u003cspan dir=\"RTL\"\u003e\u0026nbsp;\u003c/span\u003enormal saline and Itraconazole treated groups on days 7 and 13 post-Inoculation, revealed ordinary histologic appearance. No evidence of systemic cytotoxicity including hemorrhage and necrosis was observed and recorded in any group. (Fig. 9 and 10)\u003c/p\u003e"},{"header":"Discussion","content":"\u003cp\u003eIn the current study, clove essential oil, with eugenol being the main active ingredient, exhibited a high volume of 96.81% which exceeded all the previously reported studies (85\u0026ndash;90%)\u003csup\u003e14, 19\u003c/sup\u003e. Due to the numerous properties of plant compounds, particularly clove plant, in destroying various microorganisms such as bacteria and fungi\u003csup\u003e\u003cspan citationid=\"CR35\" class=\"CitationRef\"\u003e35\u003c/span\u003e\u003c/sup\u003e, as well as considering the increased resistance of \u003cem\u003eAspergillus fumigatus\u003c/em\u003e to azole antifungal drugs following some mutations such as TR34/L98H and TR46/Y121F/T289A\u003csup\u003e36\u003c/sup\u003e, extensive studies have been conducted to confirm the significant effects of minimal concentrations of plant compounds on bactericidal and fungicidal activity, particularly on \u003cem\u003eAspergillus fumigatus\u003c/em\u003e\u003csup\u003e\u003cspan citationid=\"CR27\" class=\"CitationRef\"\u003e27\u003c/span\u003e\u003c/sup\u003e. Both pure and nanoemulsion forms of clove essential oil have revealed significant bactericidal properties\u003csup\u003e\u003cspan citationid=\"CR20\" class=\"CitationRef\"\u003e20\u003c/span\u003e\u003c/sup\u003e. In the current study, MFC and MIC of clove essential oil as an herbal compound with a high percentage of eugenol showed satisfactory efficiency against \u003cem\u003eAspergillus fumigatus\u003c/em\u003e strain \u003cem\u003eATCC 13073\u003c/em\u003e comparable to Itraconazole as a commercial antifungal drug. For which the MIC for Itraconazole was calculated to be 1 \u0026micro;g/ml. This was notable as in the previous studies conducted on isolated \u003cem\u003eAspergillus fumigatus\u003c/em\u003e isolates with the TR34/L98H mutation, all had MICs greater than 1 \u0026micro;g/ml for Itraconazole and 97% had MICs greater than 1 \u0026micro;g/mL and more than 0.25 \u0026micro;g/mL for Voriconazole and Posaconazole, respectively. Also, all the isolated Aspergillus fumigatus isolates with the TR46/Y121F/T289A mutation had MICs greater than 1 \u0026micro;g/mL for Voriconazole, 76% had MICs greater than 1 \u0026micro;g/mL and 35% had MICs greater than 0.25 \u0026micro;g/mL for Itraconazole and Posaconazole, respectively\u003csup\u003e\u003cspan citationid=\"CR36\" class=\"CitationRef\"\u003e36\u003c/span\u003e\u003c/sup\u003e. Examination of the time-killing assay curve of \u003cem\u003eAspergillus fumigatus\u003c/em\u003e strain \u003cem\u003eATCC 13073\u003c/em\u003e for diverse concentrations of clove essential oil represented a similar downward trend in fungal burden and decrease (2Log) from 4 to 12 hours along with an insignificant decline from 12 to 24 hours after inoculation compared to the control sample in comparison with Itraconazole different concentrations. Similar evaluations were also reported in a study using tea tree essential oil. The pure concentration of the essential oil showed the most significant and fastest impacts with a decline of about 4Log from the initial hours of exposure (4 hours), and the dilutions showed a slower downward trend\u003csup\u003e\u003cspan citationid=\"CR28\" class=\"CitationRef\"\u003e28\u003c/span\u003e\u003c/sup\u003e. In Another study in also found that clove essential oil was able to show effective performance in controlling fungal growth and mycotoxin production in different strains of \u003cem\u003eAspergillus\u003c/em\u003e\u003csup\u003e\u003cspan citationid=\"CR37\" class=\"CitationRef\"\u003e37\u003c/span\u003e\u003c/sup\u003e. The fungicidal and bactericidal effects of clove essential oil at various concentrations against \u003cem\u003eCandida albicans\u003c/em\u003e, \u003cem\u003eEscherichia coli\u003c/em\u003e, and \u003cem\u003eStaphylococcus aureus\u003c/em\u003e had also been confirmed in previous studies\u003csup\u003e\u003cspan citationid=\"CR38\" class=\"CitationRef\"\u003e38\u003c/span\u003e\u003c/sup\u003e.\u003c/p\u003e\u003cp\u003eIn addition to extensive, in vitro investigations have been conducted on \u003cem\u003eAspergillus\u003c/em\u003e spp., in vivo studies utilizing animal models have been increased\u003csup\u003e\u003cspan citationid=\"CR15\" class=\"CitationRef\"\u003e15\u003c/span\u003e\u003c/sup\u003e. Also, today, antifungal treatment recommendations have been updated in combination of first-line and second-line medicines. Meanwhile, increasing attention has been paid to the use of new methods and combinations\u003csup\u003e\u003cspan citationid=\"CR16\" class=\"CitationRef\"\u003e16\u003c/span\u003e\u003c/sup\u003e.\u003c/p\u003e\u003cp\u003eA very high mortality rate was observed in the method of creating a pulmonary aspergillosis model with immunosuppression and persistent neutropenia in the groups without effective treatment\u003csup\u003e\u003cspan citationid=\"CR24\" class=\"CitationRef\"\u003e24\u003c/span\u003e, \u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e25\u003c/span\u003e,\u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e\u003c/sup\u003e, whereas in non-neutropenic immunosuppression method, the mortality rate of rabbits of negative control group reached zero.\u003c/p\u003e\u003cp\u003eIn addition to finding new antifungal agents, concerns regarding to establishing a rapid and definitive method for diagnosing invasive pulmonary aspergillosis and achieving a less invasive procedure for initiating antifungal treatments have caused diverse techniques such as molecular imaging and PET by using animal models have been evaluated\u003csup\u003e\u003cspan citationid=\"CR39\" class=\"CitationRef\"\u003e39\u003c/span\u003e, \u003cspan citationid=\"CR40\" class=\"CitationRef\"\u003e40\u003c/span\u003e\u003c/sup\u003e. In other similar studies, conducted on New Zealand White rabbits and using \u003cem\u003eAspergillus\u003c/em\u003e spp. such as \u003cem\u003eA\u003c/em\u003e. \u003cem\u003efumigatus\u003c/em\u003e and \u003cem\u003eA\u003c/em\u003e. \u003cem\u003etereus\u003c/em\u003e, CT scan images played an important role as a diagnostic method at different time points\u003csup\u003e\u003cspan citationid=\"CR29\" class=\"CitationRef\"\u003e29\u003c/span\u003e,\u003cspan citationid=\"CR41\" class=\"CitationRef\"\u003e41\u003c/span\u003e\u003c/sup\u003e. CT scans have also been recognized in non-neutropenic patients with nodular lesions as a diagnostic method for pulmonary aspergillosis\u003csup\u003e\u003cspan citationid=\"CR1\" class=\"CitationRef\"\u003e1\u003c/span\u003e,\u003cspan citationid=\"CR42\" class=\"CitationRef\"\u003e42\u003c/span\u003e\u003c/sup\u003e.\u003c/p\u003e\u003cp\u003eIn the current study, rabbits\u0026rsquo; CT scans have exhibited the relatively healthy lung appearance change to the involvement of various lobes after endotracheal conidial suspension inoculation. Its extension was noticeable in the negative control group. Nevertheless, in other groups treated with Itraconazole and clove essential oil, respectively, at a dose of 20 mg/kg and 10 mg/kg, less pulmonary lesions and inflammatory response, and following less nodular pulmonary involvement were evident due to their antifungal effects. After 13 days of inoculation, a slight upward trend in pulmonary lesions was observed in the negative control group, indicating the lack of effective treatment administration in this group, whereas a reduction in the pulmonary involvement and lesions indicating the significant effectiveness of the treatment in the Itraconazole group was observed. However, the group clove essential oil at dose 20 mg/kg was relatively similar at the Itraconazole group at day 7 posy-inoculation, the changes from day 7 to day 13 were insignificant in groups treated with clove essential oil. However, the lack of progression of the inflammatory response accompanied by a gentle healing process in the lung tissue at the time of using clove essential oil has been noticed.\u003c/p\u003e\u003cp\u003eNo \u003cem\u003eAspergillus fumigatus\u003c/em\u003e hyphae were observed in the examination of bronchoalveolar lavage fluid under a light microscope, which is due to the type of immunosuppression without neutropenia, where the presence of neutrophils prevented the creation of abundant fungal hyphae compared to the immunosuppression method with continuous neutropenia\u003csup\u003e\u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e5\u003c/span\u003e,\u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e,\u003cspan citationid=\"CR29\" class=\"CitationRef\"\u003e29\u003c/span\u003e\u003c/sup\u003e.\u003c/p\u003e\u003cp\u003eThe lung weight mean analysis revealed that positive control group with Itraconazole treatment had a lower mean weight, and it decreased with continued treatment. In the clove essential oil treatment groups, the mean lung weight in the group with a dose of 20 mg/kg and 10 mg/kg was respectively less than the negative control group without effective treatment and greater than the positive control group receiving Itraconazole. This reduction in mean lung weight was also evident on days 7 to 13. In other studies, conducted using immunosuppressed rabbits with persistent neutropenia and without neutropenia, a similar condition was observed in which a rise in lung weight mean among control groups without effective treatment up to more than 45 g and up to 20 g in samples treated with commercial drugs during the experiment was evident \u003csup\u003e\u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e, \u003cspan citationid=\"CR24\" class=\"CitationRef\"\u003e24\u003c/span\u003e, \u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e,\u003cspan citationid=\"CR41\" class=\"CitationRef\"\u003e41\u003c/span\u003e\u003c/sup\u003e.\u003c/p\u003e\u003cp\u003eSimilar to lung weight mean, generally BALF and lung lobes fungal burden in the group without effective treatment recorded the highest and had an upward trend from day 7 to 13 post-inoculation. In contrast, the lowest fungal burden belonged to the group with Itraconazole treatment which decreased from day 7 to 13 post-inoculation consistently. The groups treated with clove essential oil placed between these two controlled groups, and the group treated with a dose of 20 mg/kg indicated more efficient fungal burden reduction. In a study with inducing pulmonary infection in Balb C mice using intratracheal administration of lipopolysaccharide, the aqueous extract of clove plant administered intraperitoneally reduced the number of neutrophils and protein leakage into the bronchoalveolar lavage fluid significantly. In addition, in vitro study has exhibited positive effects of clove on reducing MPO activity\u003csup\u003e\u003cspan citationid=\"CR43\" class=\"CitationRef\"\u003e43\u003c/span\u003e\u003c/sup\u003e. In other similar studies, the control group without effective treatment had the highest fungal burden and the other groups treated with different agents had a lower fungal burden\u003csup\u003e\u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e,\u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e,\u003cspan citationid=\"CR41\" class=\"CitationRef\"\u003e41\u003c/span\u003e\u003c/sup\u003e.\u003c/p\u003e\u003cp\u003eVital organs\u0026rsquo; examination in two ways of macroscopic and microscopic showed no signs of cellular and systemic toxicity due to using clove essential oil compared to the control groups. In the other studies conducted, no evidence of cytotoxicity has been reported so far\u003csup\u003e\u003cspan citationid=\"CR35\" class=\"CitationRef\"\u003e35\u003c/span\u003e,\u003cspan citationid=\"CR44\" class=\"CitationRef\"\u003e44\u003c/span\u003e\u003c/sup\u003e. In addition, the absence of subchronic toxicity and mutagenicity has been confirmed concerning the polyphenolic extract of clove seeds\u003csup\u003e\u003cspan citationid=\"CR45\" class=\"CitationRef\"\u003e45\u003c/span\u003e\u003c/sup\u003e.\u003c/p\u003e\u003cp\u003eIn a similar attitude to using herbal compounds, extensive studies exist one of which has revealed the active ingredient cinnamaldehyde, obtained from the essential oil of cinnamon from the \u003cem\u003eLauraceae\u003c/em\u003e family, can have a significant antifungal effect in an animal model of invasive pulmonary aspergillosis in immunosuppressed ICR mice\u003csup\u003e\u003cspan citationid=\"CR46\" class=\"CitationRef\"\u003e46\u003c/span\u003e\u003c/sup\u003e. Another study, however, revealed a significant effect in eliminating \u003cem\u003eAspergillus\u003c/em\u003e and reducing damage to lung tissue silver nanoparticles from the essential oil of \u003cem\u003eArtemisia sieberi\u003c/em\u003e in Swiss albino mice after inducing immunosuppression with neutropenia and infection with the fungus \u003cem\u003eAspergillus fumigatus\u003c/em\u003e by intranasal administration\u003csup\u003e\u003cspan citationid=\"CR47\" class=\"CitationRef\"\u003e47\u003c/span\u003e\u003c/sup\u003e. In another similar study, the antifungal activity of gold nanoparticles of \u003cem\u003eLeptadena hastata\u003c/em\u003e essential oil was investigated and confirmed in Swiss albino mice\u003csup\u003e\u003cspan citationid=\"CR48\" class=\"CitationRef\"\u003e48\u003c/span\u003e\u003c/sup\u003e. Another example of these studies is the demonstration of the antifungal effect of \u003cem\u003eCalotropis gigantean\u003c/em\u003e extract in a model of invasive pulmonary aspergillosis in neutropenic mice\u003csup\u003e\u003cspan citationid=\"CR49\" class=\"CitationRef\"\u003e49\u003c/span\u003e\u003c/sup\u003e. Not only have herbal agents\u0026rsquo; efficiency in antifungal therapy been evaluated, but also their other potentials particularly about clove plant have been of great interests. So, in a study, it was found that the use of clove essential oil encapsulated by nanofibers shows sound effects on wound healing and antimicrobial activity against \u003cem\u003eEscherichia coli\u003c/em\u003e and \u003cem\u003eStaphylococcus aureus\u003c/em\u003e\u003csup\u003e\u003cspan citationid=\"CR50\" class=\"CitationRef\"\u003e50\u003c/span\u003e\u003c/sup\u003e. In addition to its bactericidal properties, eugenol has been shown having properties in eliminating parasites such as \u003cem\u003eGiardia lamblia\u003c/em\u003e, \u003cem\u003eFasciola gigantica\u003c/em\u003e, \u003cem\u003eHaemonchus contortus\u003c/em\u003e, and \u003cem\u003eSchistosoma mansoni\u003c/em\u003e\u003csup\u003e\u003cspan citationid=\"CR51\" class=\"CitationRef\"\u003e51\u003c/span\u003e\u003c/sup\u003e. In this regard, the relative effectiveness of clove essential oil in improving liver lesions was observed in a study which was conducted using various plant essential oils, including clove essential oil, on rabbits infected with \u003cem\u003eEimeria estidae\u003c/em\u003e\u003csup\u003e\u003cspan citationid=\"CR52\" class=\"CitationRef\"\u003e52\u003c/span\u003e\u003c/sup\u003e. In another study using cold-pressed clove oil, its protective properties against liver cells being damaged by CCL4 were noted, which may indicate that clove products, in addition to not having toxic effects and causing toxicity lesions, have significant effectiveness in improving hepatotoxic lesions induced, probably due to antioxidant compounds\u003csup\u003e\u003cspan citationid=\"CR53\" class=\"CitationRef\"\u003e53\u003c/span\u003e\u003c/sup\u003e. In a study in 2016, the protective effect of clove powder was also evident in rabbits, as in the group that first received paracetamol, liver enzymes including ALT, AST, GGT, ALP and LDH substantially increased after receiving clove powder, and decreased after administration. No changes were observed in the group that received it simultaneously\u003csup\u003e\u003cspan citationid=\"CR54\" class=\"CitationRef\"\u003e54\u003c/span\u003e\u003c/sup\u003e. In a study on rats in which diabetes mellitus was induced, the anti-hyperglycemic effects of aqueous extracts of various plants, including \u003cem\u003eSyzgium cumini\u003c/em\u003e (Jamun), were evaluated. The results of this study confirmed the reducing effect on blood sugar levels and weight changes in diabetic rats\u003csup\u003e\u003cspan citationid=\"CR55\" class=\"CitationRef\"\u003e55\u003c/span\u003e\u003c/sup\u003e. In another study, clove essential oil emulsion showed significant antidiabetic properties using alpha-amylase and starch enzymes\u003csup\u003e\u003cspan citationid=\"CR56\" class=\"CitationRef\"\u003e56\u003c/span\u003e\u003c/sup\u003e. In a study, in rats been induced with oxidative stress by H2O2, administration of clove essential oil resulted in positive effects in brain, liver, and kidney tissues, as well as blood biochemical indicators\u003csup\u003e\u003cspan citationid=\"CR57\" class=\"CitationRef\"\u003e57\u003c/span\u003e\u003c/sup\u003e. Clove essential oil is also known as an antioxidant compound in food and pharmaceutical compositions by increasing the shelf life and maintaining their nutritional properties\u003csup\u003e\u003cspan citationid=\"CR58\" class=\"CitationRef\"\u003e58\u003c/span\u003e\u003c/sup\u003e. In a study, it was found that low doses of clove essential oil could be effective in improving and controlling oxidative stress, apoptosis, and excessive autophagy\u003csup\u003e\u003cspan citationid=\"CR59\" class=\"CitationRef\"\u003e59\u003c/span\u003e\u003c/sup\u003e. In addition, in another study, it was found that short-term consumption of clove essential oil can have antidepressant properties and long-term consumption has anti-stress properties by improving the hippocampal pERK1/2-pCREB-BDNF pathway in rats\u003csup\u003e\u003cspan citationid=\"CR60\" class=\"CitationRef\"\u003e60\u003c/span\u003e\u003c/sup\u003e.\u003c/p\u003e\u003cp\u003eIn current study, in the macroscopic and microscopic examination of lung tissue, pulmonary lesions in the negative control group were much more severe compared with the other groups accompanied by an upward trend from day 7 to 13 post-inoculation. Conversely, the positive control group being treated with Itraconazole showed the mildest pulmonary lesions with a declining and recovery tendency from day 7 to 13 post-inoculation. The groups treated with clove essential oil the extent and following reduction of pulmonary lesions was generally slightly greater in the group treated with a dose of 20 mg/kg.\u003c/p\u003e\u003cp\u003eComparison of histopathological findings of the current study with others represented similar pulmonary lesions. As in studies by using immunosuppressed rabbits with both non-neutropenic and persistent neutropenia and treated with the commercial antifungal drugs such as amphotericin B, extensive fungal hyphal formation and extensive tissue necrosis with vascular infiltration and extensive hemorrhage and vascular thrombosis without significant inflammatory cell infiltration were observed in the persistent neutropenic groups compared to untreated control rabbits without neutropenia. However, in the non-neutropenic groups, the predominant lesions were inflammatory cell accumulation in the form of granulomas containing neutrophils and macrophages, necrosis and without extensive fungal hyphal formation. In the treated rabbits, the group of immunosuppressed rabbits without neutropenia also showed a better condition\u003csup\u003e\u003cspan citationid=\"CR24\" class=\"CitationRef\"\u003e24\u003c/span\u003e,\u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e25\u003c/span\u003e,\u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e\u003c/sup\u003e.\u003c/p\u003e\u003cp\u003eIn addition, the type M1 macrophages\u0026rsquo; ratio in the negative control group was higher than in the other groups, which could be due to the high level of fungal infection and burden. The population of M2 macrophages was also higher in the negative control group than in the other groups due to the effect of the fungus regarding higher burden. It should be noted that it has been shown that \u003cem\u003eAspergillus fumigatus\u003c/em\u003e can cause a change in the phenotype of activated macrophages to M2 type by upregulating M2 macrophage markers such as transcripts of the gene encoding arginase-1 (Arg1), Ym1, and CD206\u003csup\u003e5\u003c/sup\u003e. This was consistent with the control group without effective treatment. In the treated groups, itraconazole, clove essential oil 20 mg/kg and 10 mg/kg groups were in better condition and antigen expression was lower, respectively. The expression of neutrophil-specific marker was relatively analogous related to extension of pulmonary involvement and fungal burden in diverse groups. It should be noted that the effect of clove essential oil in regulating the immune response has been investigated and confirmed in both the humoral and cell-mediated immune systems\u003csup\u003e\u003cspan citationid=\"CR61\" class=\"CitationRef\"\u003e61\u003c/span\u003e\u003c/sup\u003e. It was also determined that the components of clove can suppress the release of interferon gamma, and induce the secretion of interleukins 4 and 10, as well as TGF-B and as a result can suppress T lymphocyte cellular immunity and increase humoral immune responses, so that the cytokine pattern changes towards Th2 and regulatory responses and increases humoral immune cytokines\u003csup\u003e\u003cspan citationid=\"CR62\" class=\"CitationRef\"\u003e62\u003c/span\u003e\u003c/sup\u003e.\u003c/p\u003e\u003cp\u003eNotwithstanding most pathological findings has been related to experimental studies, a case report study has represented the pulmonary lesions including scattered nodular lesions throughout the lungs on macroscopic examination and the presence of multiple pyogranulomatous lesions with the formation of asteroid bodies, infiltration of neutrophils, epithelioid macrophages, and the formation of multinucleated giant cells on microscopic examination of apparently healthy rabbits which infected by \u003cem\u003eAspergillus\u003c/em\u003e\u003csup\u003e\u003cspan citationid=\"CR63\" class=\"CitationRef\"\u003e63\u003c/span\u003e\u003c/sup\u003e.\u003c/p\u003e"},{"header":"Conclusion","content":"\u003cp\u003eSummarily, the current study represented that clove essential oil had a significant and important effectiveness in inhibiting the growth and even eliminating \u003cem\u003eAspergillus fumigatus\u003c/em\u003e strain \u003cem\u003eATCC 13073\u003c/em\u003e, as a filamentous fungus, compared to Itraconazole, as a commercial medicine, from the azole family in in vitro experiment. In in vivo experiments, the findings related to CT scan images, lung tissue weight, bronchoalveolar lavage fluid and lung tissue fungal burden, and macroscopic and microscopic lung examination were very consistent, and an increasing trend was observed in the negative control group without receiving effective treatment, and a decreasing trend and improvement were observed in the groups treated with Itraconazole and different doses of clove essential oil in two time periods of 7 and 13 days post-inoculation to \u003cem\u003eAspergillus fumigatus\u003c/em\u003e strain \u003cem\u003eATCC 13073\u003c/em\u003e, even though the changes sometimes were slight and differences might be scant between them. It can also be noted that the findings of the current study were consistent with most other studies, both in vitro and in vivo. An Essential point in this study was that although Itraconazole showed more significant results in terms of reducing the fungal burden in the tissue and reducing the extent of pulmonary involvement and lesions than other groups, clove essential oil without causing symptoms of systemic toxicity at a higher dose exhibited relatively better performance compared to a lower dose. Both groups treated with clove essential oil showed effective results compared to the negative control group without receiving effective treatment. This could suggest that if clove essential oil were administered at higher doses, different time intervals, or different formulations, better results might be observed in reducing the fungal burden, inflammatory response, and pulmonary lesions.\u003c/p\u003e\u003cp\u003eThe following are suggestions for conducting additional studies in this field, such as using other forms of clove essential oil to improve absorption and performance, such as Nano-compounds and emulsions, increasing the drug dose or administration intervals, using a combination of a commercial drug and clove essential oil, and comparing the performance of clove essential oil in reducing fungal lesions in two different groups of filamentous and yeast fungi.\u003c/p\u003e"},{"header":"Declarations","content":"\u003ch2\u003eAuthor Contribution\u003c/h2\u003e\u003cp\u003eS.Sh.: Conceptualization, Investigation, Formal analysis, Methodology, Histopathological investigations, Validation, Visualization, Project administration, Writing - Review and Editing. M.L.: Conceptualization, Original draft, Investigation, Formal analysis, Methodology, Validation, Visualization, Software, Writing - Review and Editing, Molecular investigations. A.Sh.: Conceptualization, Investigation, Formal analysis, Methodology, Molecular investigations, Writing, Review and Editing. M.M.: CT scans investigations, Review and Editing, Conceptualization, Investigation, Formal analysis, Methodology. F.S.: Conceptualization, Review and Editing. R.I.N.: Daily monitoring, Intubation. Gh.V.: Daily Monitoring, Drug injection. All authors have read and agreed to the final version of the manuscript.\u003c/p\u003e\u003ch2\u003eAcknowledgement\u003c/h2\u003e\u003cp\u003eThe authors wish to express their appreciation to everyone that assists us in this study.\u003c/p\u003e\u003ch2\u003eData Availability\u003c/h2\u003e\u003cp\u003eThe datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\n \u003cli\u003eKanj, A., Abdallah, N. \u0026amp; Soubani, A. O. The spectrum of pulmonary aspergillosis. \u003cem\u003eRespir. Med\u003c/em\u003e. \u003cstrong\u003e141,\u003c/strong\u003e 121-131. https://doi.org/10.1016/j.rmed.2018.06.029 (2018).\u003c/li\u003e\n \u003cli\u003eBouyssi, A. \u003cem\u003eet al.\u003c/em\u003e Characterization of Lung Inflammatory Response to Aspergillus fumigatus Spores.\u003cem\u003e\u0026nbsp;J. Fungi (Basel).\u0026nbsp;\u003c/em\u003e\u003cstrong\u003e17\u003c/strong\u003e, 682. https://doi.org/10.3390/jof9060682 (2023).\u003c/li\u003e\n \u003cli\u003eUllmann, I., Aregger, A., Leip, S. L. \u0026amp; Zimmerli, S. Caspofungin Cerebral Penetration and Therapeutic Efficacy in Experimental Cerebral Aspergillosis. \u003cem\u003eMicrobiol. Spectr\u003c/em\u003e. \u003cstrong\u003e10,\u003c/strong\u003e e02753-21. https://doi.org/10.1128/spectrum.02753-21 (2022).\u003c/li\u003e\n \u003cli\u003ePetraitis, V. \u003cem\u003eet al\u003c/em\u003e. Combination Therapy with Ibrexafungerp (Formerly SCY-078), a First-in-Class Triterpenoid Inhibitor of (1\u0026rarr;3)-\u0026beta;-D-Glucan Synthesis, and Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis. \u003cem\u003eAntimicrob. Agents. Ch\u003c/em\u003e. \u003cstrong\u003e64,\u003c/strong\u003e e02429-19. https://doi.org/10.1128/aac.02429-19 (2020).\u003c/li\u003e\n \u003cli\u003eXu, S. \u0026amp;Shinohara, M. L. Tissue-Resident Macrophages in Fungal infections. \u003cem\u003eFront. Immunol\u003c/em\u003e. \u003cstrong\u003e8,\u003c/strong\u003e 01798. https://doi.org/10.3389/fimmu.2017.01798 (2017).\u003c/li\u003e\n \u003cli\u003eBen-Ghazzi, N. \u003cem\u003eet al\u003c/em\u003e. Characterisation of Aspergillus fumigatus Endocytic Trafficking within Airway Epithelial Cells Using High-Resolution Automated Quantitative Confocal Microscopy. \u003cem\u003eJ. Fungi (Basel).\u003c/em\u003e \u003cstrong\u003e7,\u003c/strong\u003e 454. https://doi.org/10.3390/jof7060454 (2021).\u003c/li\u003e\n \u003cli\u003eBassetti, M. \u003cem\u003eet al\u003c/em\u003e. How to manage aspergillosis in non-neutropenic intensive care unit patients. \u003cem\u003eCrit. Care.\u003c/em\u003e \u003cstrong\u003e18,\u003c/strong\u003e 458. https://doi.org/10.1186/s13054-014-0458-4 (2014).\u003c/li\u003e\n \u003cli\u003eSk\u0026oacute;ra, M. \u003cem\u003eet al\u003c/em\u003e. COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit Patients from Poland. \u003cem\u003eJ. Fungi\u003c/em\u003e. \u003cstrong\u003e9,\u003c/strong\u003e 666. https://doi.org/10.3390/jof9060666 (2023).\u003c/li\u003e\n \u003cli\u003eLedoux, M. P. \u003cem\u003eet al\u003c/em\u003e. Invasive Pulmonary Aspergillosis. \u003cem\u003eSemin. Respir. Crit. Care Med\u003c/em\u003e. \u003cstrong\u003e41,\u003c/strong\u003e 80-98. https://doi.org/10.1055/s-0039-3401990 (2020).\u003c/li\u003e\n \u003cli\u003eShibuya, k. \u003cem\u003eet al.\u003c/em\u003e Pathophysiology of pulmonary aspergillosis. \u003cem\u003eJ Infect Chemother\u003c/em\u003e. \u003cstrong\u003e10,\u003c/strong\u003e 138-145. https://doi.org/10.1007/s10156-004-0315-5 (2004).\u003c/li\u003e\n \u003cli\u003eGaffney, S., Kelly, D.M., Rameli, P.M., Kelleher, E. \u0026amp; Martin-Loeches, I. Invasive pulmonary aspergillosis in the intensive care unit: current challenges and best practices. \u003cem\u003eActa Pathol. Microbiol. Scand.\u003c/em\u003e \u003cstrong\u003e131,\u003c/strong\u003e 654-667. https://doi.org/10.1111/apm.13316 (2023)\u003c/li\u003e\n \u003cli\u003eTrof, R. J., Beishuizen, A., Debets-Ossenkopp, Y. J., Girbes, A. R. J. \u0026amp; Groeneveld, A. B. J. Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients. \u003cem\u003eIntensive. Care. Med\u003c/em\u003e. \u003cstrong\u003e33,\u003c/strong\u003e 1694-1703. https://doi.org/10.1007/s00134-007-0791-z (2007).\u003c/li\u003e\n \u003cli\u003eRishi, A. \u003cem\u003eet al\u003c/em\u003e. Invasive Pulmonary Aspergillosis in Critically Ill Apparently Immunocompetent Patients. \u003cem\u003eClin. Pulm. Med.\u003c/em\u003e \u003cstrong\u003e23,\u003c/strong\u003e 184-187. https://doi.org/10.1097/CPM.0000000000000161 (2016)\u003c/li\u003e\n \u003cli\u003ePinto, E., Vale-Silva, L., Cavaleiro, C., \u0026amp; Salgueiro, L. Antifungal activity of the clove essential oil from Syzygium aromaticum on Candida, Aspergillus and dermatophyte species\u003cem\u003e.\u0026nbsp;\u003c/em\u003e\u003cem\u003eJ. Med. Microbiol.\u003c/em\u003e \u003cstrong\u003e58,\u003c/strong\u003e 1454-1462. https://doi.org/10.1099/jmm.0.010538-0 (2009).\u003c/li\u003e\n \u003cli\u003eWalsh, T. J., Petraitiene, R., \u0026amp; Petraitis, V. Modeling Invasive Aspergillosis: How Close Are Predicted Antifungal Targets?. \u003cem\u003eJ. Fungi.\u0026nbsp;\u003c/em\u003e\u003cstrong\u003e6,\u003c/strong\u003e 198. https://doi.org/10.3390/jof6040198 (2020).\u003c/li\u003e\n \u003cli\u003eBrunet, K. \u0026amp; Rammaert, B. Mucormycosis treatment: recommendations, latest advances, and perspectives. \u003cem\u003eJ. Mycol. Med.\u0026nbsp;\u003c/em\u003e\u003cstrong\u003e30,\u003c/strong\u003e 101007. https://doi.org/10.1016/j.mycmed.2020.101007 (2020).\u003c/li\u003e\n \u003cli\u003eNatu, K. N., \u0026amp; Tatke, P. A. Essential oils-prospective candidates for antifungal treatment?. \u003cem\u003eJ. Essent. Oil Res\u003c/em\u003e. \u003cstrong\u003e31,\u003c/strong\u003e 347-360. https://doi.org/10.1080/10412905.2019.1604437 (2019).\u003c/li\u003e\n \u003cli\u003eNiazi, M. K. \u003cem\u003eet al\u003c/em\u003e. Therapeutic and Nutritional Effect of Clove: A Miracle Spice. \u003cem\u003ePak. biomed. j\u003c/em\u003e. \u003cstrong\u003e5,\u003c/strong\u003e 12-15. https://doi.org/10.54393/pbmj.v5i9.798 (2022).\u003c/li\u003e\n \u003cli\u003eIdowu, S., Adekoya, A.E., Igiehon, O.O. \u0026amp; Idowu, A.T. Clove (\u003cem\u003eSyzygium aromaticum\u003c/em\u003e) spices: A review on their bioactivities, current use, and potential application in dairy products. \u003cem\u003eJ. Food. Meas. Charact\u003c/em\u003e. \u003cstrong\u003e\u003cem\u003e15\u003c/em\u003e,\u003c/strong\u003e 3419-3435. https://doi.org/10.1007/s11694-021-00915-9 (2021).\u003c/li\u003e\n \u003cli\u003eHaro-Gonz\u0026aacute;lez, J.N., Schlienger de Alba, B.N., Mart\u0026iacute;nezVel\u0026aacute;zquez, M., Castillo-Herrera, G.A. \u0026amp; Espinosa-Andrews, H. Optimization of Clove Oil Nanoemulsions: Evaluation of Antioxidant, Antimicrobial, and Anticancer Properties. \u003cem\u003eColloids. Interfaces\u003c/em\u003e. \u003cstrong\u003e7,\u003c/strong\u003e 64. https://doi.org/10.3390/colloids7040064 (2023).\u003c/li\u003e\n \u003cli\u003eKhan, M. S. A. \u0026amp; Ahmad, I. In vitro antifungal, anti-elastase and anti-keratinase activity of essential oils of Cinnamomum-, Syzygium- and Cymbopogon-species against Aspergillus fumigatus and Trichophyton rubrum. \u003cem\u003ePhytomedicine.\u003c/em\u003e \u003cstrong\u003e19,\u003c/strong\u003e 48-55. https://doi.org/10.1016/j.phymed.2011.07.005 (2011).\u003c/li\u003e\n \u003cli\u003eUniyal, V., Bhatt, R. P., Saxena, S. \u0026amp; Talwar, A. Antifungal activity of essential oils and their volatile constituents against respiratory tract pathogens causing Aspergilloma and Aspergillosis by gaseous contact. \u003cem\u003eJ. Appl. Nat. Sci.\u003c/em\u003e \u003cstrong\u003e4,\u003c/strong\u003e 65-70. (2012).\u003c/li\u003e\n \u003cli\u003ePatterson, T. F. The future of animal models of invasive aspergillosis. \u003cem\u003eMed. Mycol.\u003c/em\u003e \u003cstrong\u003e43,\u003c/strong\u003e 115-119. https://doi.org/10.1080/13693780400029429 (2005).\u003c/li\u003e\n \u003cli\u003eBerenguer, J. \u003cem\u003eet al\u003c/em\u003e. Pathogenesis of Pulmonary Aspergillosis Granulocytopenia versus Cyclosporine and Methylprednisolone-Induced Immunosuppression. \u003cem\u003eAm. J. Respir. Crit. Care Med.\u003c/em\u003e \u003cstrong\u003e152,\u003c/strong\u003e 1079-1086 https://doi.org/10.1164/ajrccm.152.3.7663787 (1995).\u003c/li\u003e\n \u003cli\u003eBerenguer J, \u003cem\u003eet\u003c/em\u003e \u003cem\u003eal\u003c/em\u003e. Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma. \u003cem\u003eAntimicrob.\u003c/em\u003e \u003cem\u003eAgents.\u003c/em\u003e \u003cem\u003eChemother\u003c/em\u003e. \u003cstrong\u003e38,\u0026nbsp;\u003c/strong\u003e1303-8. https://doi.org/10.1128/AAC.38.6.1303 (1994)\u003c/li\u003e\n \u003cli\u003ePetraitiene, R., Petraitis, V., Bacher, J. D., Finkelman, M. A. \u0026amp; Walsh, T. J. Effects of host response and antifungal therapy on serum and BAL levels of galactomannan and (1\u0026rarr;3)-\u0026beta;-D-glucan in experimental invasive pulmonary aspergillosis. \u003cem\u003eMed. Mycol.\u003c/em\u003e \u003cstrong\u003e53,\u003c/strong\u003e 558-568. https://doi.org/10.1093/mmy/myv034 (2015).\u003c/li\u003e\n \u003cli\u003eSuleiman, M. M., McGaw, L. J., Naidoo, V. \u0026amp; Eloff, J. N. Evaluation of several tree species for activity against the animal fungal pathogen Aspergillus fumigatus. \u003cem\u003eS Afr J Bot.\u003c/em\u003e \u003cstrong\u003e76,\u003c/strong\u003e 64-71. https://doi.org/10.1016/j.sajb.2009.07.001 (2010).\u003c/li\u003e\n \u003cli\u003eHomeyer, D. C. \u003cem\u003eet al\u003c/em\u003e. In Vitro activity of Melaleuca alternifolia (tea tree) oil on filamentous fungi and toxicity to human cells. \u003cem\u003eMed Mycol\u003c/em\u003e. \u003cstrong\u003e53,\u003c/strong\u003e 285-294. https://doi.org/10.1093/mmy/myu072 (2015).\u003c/li\u003e\n \u003cli\u003eWalsh, T.J. \u003cem\u003eet al.\u003c/em\u003e Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B. \u003cem\u003eJ. Infect. Dis.\u003c/em\u003e \u003cstrong\u003e188,\u003c/strong\u003e 305-319. https://doi.org/10.1086/377210 (2003).\u003c/li\u003e\n \u003cli\u003eLeary, S\u003cem\u003e. et al.\u003c/em\u003e AVMA Guidelines for the Euthanasia of Animals: 2020 Edition. American Veterinary Medical Association. 1-121. (2020)\u003c/li\u003e\n \u003cli\u003eLuna, L.G. \u003cem\u003eManual of histological staining methods of the armed forces Institute of Pathology\u003c/em\u003e. In: \u003cem\u003eManual of histologic staining methods of the Armed Forces Institute of Pathology\u003c/em\u003e (1968).\u003c/li\u003e\n \u003cli\u003eTaylor, C.R., Shi, S.R., Barr, N.J. \u0026amp; Wu, N. Techniques of immunohistochemistry: principles, pitfalls, and standardization. \u003cem\u003eIn\u003c/em\u003e: \u003cem\u003eDiagnostic Immunohistochemistry\u003c/em\u003e (ed. Dabbs, D.J) (New York, NY, 2002).\u003c/li\u003e\n \u003cli\u003eDu Sert, N.P. \u003cem\u003eet al\u003c/em\u003e. Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. \u003cem\u003ePLoS. Boil\u003c/em\u003e. \u003cstrong\u003e18,\u003c/strong\u003e e3000411. https://doi.org/10.1371/journal.pbio.3000411 (2020).\u003c/li\u003e\n \u003cli\u003eLalepoor, M., Shokrpoor, S., Sasani, F., Sharifzadeh, A. \u0026amp; Masoudifard ,M. Histopathological Assessment of Cyclosporine and Methylprednisolone-Induced Invasive Pulmonary Aspergillosis in Rabbits, \u003cem\u003eIran. J. Vet. Med\u003c/em\u003e. https://doi.org/10.22059/ijvm.2025.389435.1005734 (2025).\u003c/li\u003e\n \u003cli\u003eXue Q, Xiang Z, Wang S, Cong Z, Gao P and Liu X Recent advances in nutritional composition, phytochemistry, bioactive, and potential applications of Syzygium aromaticum L. (Myrtaceae). \u003cem\u003eFront. Nutr.\u0026nbsp;\u003c/em\u003e\u003cstrong\u003e9\u003c/strong\u003e,1002147. https://doi.org/10.3389/fnut.2022.1002147 (2022).\u003c/li\u003e\n \u003cli\u003eBuil, J.B., Hagen, F., Chowdhary, A., Verweij, P.E. \u0026amp; Meis, J.F. Itraconazole, Voriconazole, and Posaconazole CLSI MIC Distributions for Wild-Type and Azole-Resistant Aspergillus fumigatus Isolates. \u003cem\u003eJ Fungi (Basel).\u0026nbsp;\u003c/em\u003e\u003cstrong\u003e4,\u003c/strong\u003e103. https://doi.org/10.3390/jof4030103 (2018).\u003c/li\u003e\n \u003cli\u003eLaaziz, A. \u003cem\u003eet al\u003c/em\u003e. Activity of essential oils from Syzygium aromaticum and Rosmarinus officinalis against growth and ochratoxin A production by Aspergillus tubingensis and Aspergillus luchuensis from Moroccan grapes. \u003cem\u003ePhytopathol. Mediterr\u003c/em\u003e\u003cem\u003e.\u003c/em\u003e \u003cstrong\u003e61,\u003c/strong\u003e 299-310. https://doi.org/10.36253/phyto-12841 (2022).\u003c/li\u003e\n \u003cli\u003eSuflet, D.M. \u003cem\u003eet al\u003c/em\u003e. Chitosan\u0026ndash;Oxidized Pullulan Hydrogels Loaded with Essential Clove Oil: Synthesis, Characterization, Antioxidant and Antimicrobial Properties. \u003cem\u003egels\u003c/em\u003e. \u003cstrong\u003e10,\u003c/strong\u003e 227. https://doi.org/10.3390/gels10040227 (2024).\u003c/li\u003e\n \u003cli\u003eMisslinger, M. \u003cem\u003eet al\u003c/em\u003e. Desferrioxamine B-Mediated Pre-Clinical In Vivo Imaging of Infection by the Mold Fungus Aspergillus fumigatus. \u003cem\u003eJ Fungi (Basel).\u003c/em\u003e \u003cstrong\u003e7,\u003c/strong\u003e 734. https://doi.org/10.3390/jof7090734 (2021).\u003c/li\u003e\n \u003cli\u003eGunzer, M., Thornton, C.R. \u0026amp; Beziere, N. Advances in the In Vivo Molecular Imaging of Invasive Aspergillosis. \u003cem\u003eJ Fungi (Basel).\u003c/em\u003e \u003cstrong\u003e6,\u003c/strong\u003e 338. https://doi.org/10.3390/jof6040338 (2020).\u003c/li\u003e\n \u003cli\u003ePetraitis, V. \u003cem\u003eet al\u003c/em\u003e. Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin. \u003cem\u003eJ Infect Dis.\u003c/em\u003e \u003cstrong\u003e187,\u003c/strong\u003e1834-1843. https://doi.org/10.1086/375420 (2003).\u003c/li\u003e\n \u003cli\u003eBassetti, M., Carnelutti, A., Righi, E., Corcione, S. \u0026amp; De Rosa, F. G. Current Pharmacological Treatment of Pulmonary Aspergillosis. \u003cem\u003eClin. Pulm. Med\u003c/em\u003e. \u003cstrong\u003e22,\u003c/strong\u003e 205-214. https://doi.org/10.1097/CPM.0000000000000096 (2015).\u003c/li\u003e\n \u003cli\u003eChniguira, A., Ziouda, F., Marzaiolic, V., El-Bennac, J. \u0026amp; Bachoual, R. Syzygium aromaticum aqueous extract inhibits human neutrophils myeloperoxidase and protects mice from LPS-induced lung inflammation. \u003cem\u003ePharm. Biol.\u003c/em\u003e \u003cstrong\u003e1,\u003c/strong\u003e 56-64 https://doi.org/10.1080/13880209.2018.1557697 (2018).\u003c/li\u003e\n \u003cli\u003eAfanyibo, Y.G. \u003cem\u003eet al.\u003c/em\u003e Toxicity and antioxidant activity of Syzygium aromaticum, Mondia whitei, Carissa spinarum and Caesalpinia bonduc. \u003cem\u003eJ Phytopharmacol.\u003c/em\u003e \u003cstrong\u003e8,\u003c/strong\u003e124-128. https://doi.org/10.31254/phyto.2019.8307 (2019).\u003c/li\u003e\n \u003cli\u003eVijayasteltar, L., Gopinathan, Nair, G., Balu Maliakel, b. \u0026amp; Ramadasan Kuttana Krishnakumar I.M. Safety assessment of a standardized polyphenolic extract of clove buds: Subchronic toxicity and mutagenicity studies. \u003cem\u003eToxicol. Rep\u003c/em\u003e\u003cem\u003e.\u003c/em\u003e \u003cstrong\u003e3,\u003c/strong\u003e 439-449. https://doi.org/10.1016/j.toxrep.2016.04.001 (2016).\u003c/li\u003e\n \u003cli\u003eLiua, X., Luo, J., Dengc, J., Li, J., \u0026amp; Wang, G. In vivo investigation of antimicrobial effects of cinnamaldehyde using immunosuppressed ICR mice with invasive pulmonary aspergillosis. \u003cem\u003eChin. Herb. Med.\u003c/em\u003e \u003cstrong\u003e11,\u003c/strong\u003e 429-433. https://doi.org/10.1016/j.chmed.2019.09.004 (2019).\u003c/li\u003e\n \u003cli\u003eAli, E. M. \u0026amp; Abdallah, B. M. Effective Inhibition of Invasive Pulmonary Aspergillosis by Silver Nanoparticles Biosynthesized with Artemisia sieberi Leaf Extract. \u003cem\u003eNanomaterials.\u003c/em\u003e \u003cstrong\u003e12,\u0026nbsp;\u003c/strong\u003e51. https://doi.org/10.3390/nano12010051 (2022).\u003c/li\u003e\n \u003cli\u003eAbdallah, B. M. \u0026amp; Ali, E. M. Therapeutic Potential of Green Synthesized Gold Nanoparticles Using Extract of Leptadenia hastata against Invasive Pulmonary Aspergillosis. \u003cem\u003eJ. Fungi\u003c/em\u003e. \u003cstrong\u003e8,\u003c/strong\u003e 442. https://doi.org/10.3390/jof8050442 (2022).\u003c/li\u003e\n \u003cli\u003eAli, E. M., Alfwuaires, M. A. \u0026amp; Badr, G. M. Therapeutic potential of Calotropis gigantea extract against invasive pulmonary aspergillosis: In vitro and in vivo study. \u003cem\u003eAsian. Pac. J. Trop. Biomed\u003c/em\u003e\u003cstrong\u003e.\u003c/strong\u003e \u003cstrong\u003e12,\u003c/strong\u003e 243-252 (2022).\u003c/li\u003e\n \u003cli\u003eHameed, M. \u003cem\u003eet al\u003c/em\u003e. Formulation and Evaluation of a Clove Oil-Encapsulated Nanofiber Formulation for Effective Wound-Healing. \u003cem\u003eMolecules\u003c/em\u003e. \u003cstrong\u003e26,\u003c/strong\u003e 2491. https://doi.org/10.3390/molecules26092491 (2021).\u003c/li\u003e\n \u003cli\u003eBatiha, G.E. \u003cem\u003eet al.\u003c/em\u003e Syzygium aromaticum L. (Myrtaceae): Traditional Uses, Bioactive Chemical Constituents, Pharmacological and Toxicological Activities. \u003cem\u003eBiomolecules.\u003c/em\u003e \u003cstrong\u003e10,\u003c/strong\u003e 202. https://doi.org/10.3390/biom10020202 (2020).\u003c/li\u003e\n \u003cli\u003eSorour, S.S. \u003cem\u003eet al\u003c/em\u003e. Anticoccidial and hepatoprotective effects of artemisinin liquid extract, cinnamon essential oil and clove essential oil against Eimeria stiedae infection in rabbits. \u003cem\u003eTrop. Biomed.\u003c/em\u003e \u003cstrong\u003e35,\u003c/strong\u003e 926-943 (2018).\u003c/li\u003e\n \u003cli\u003eEl-Hadary, A.E. \u0026amp; Ramadan Hassanien, M.F. Hepatoprotective effect of cold-pressed Syzygium aromaticum oil against carbon tetrachloride (CCl4)-induced hepatotoxicity in rats. \u003cem\u003ePharm. Biol.\u003c/em\u003e \u003cstrong\u003e\u003cem\u003e54\u003c/em\u003e\u003c/strong\u003e\u003cstrong\u003e,\u003c/strong\u003e 1364-1372.http://dx.doi.org/10.3109/13880209.2015.1078381 (2016).\u003c/li\u003e\n \u003cli\u003eKazi, S., Abbasi, P. \u0026amp; Arain, A.A. Syzygium aromaticum: A potential hepatoprotective agent. \u003cem\u003eJ. Sheikh. Zayed. Med. Coll\u003c/em\u003e. \u003cstrong\u003e\u003cem\u003e7\u003c/em\u003e,\u003c/strong\u003e 956-959. (2016).\u003c/li\u003e\n \u003cli\u003eGupta, R. \u0026amp; Sharma, A. Anti-hyperglycemic activity of aqueous extracts of some medicinal plants on wistar rats. \u003cem\u003eJ Diabetes Metab\u003c/em\u003e, \u003cstrong\u003e\u003cem\u003e8\u003c/em\u003e,\u003c/strong\u003e 752. https://doi.org/10.4172/2155-6156.1000752 (2017).\u003c/li\u003e\n \u003cli\u003eTahir, H. U., Sarfraz, R. A., Ashraf, A., \u0026amp; Adil, S. Chemical Composition and Antidiabetic Activity of Essential Oils Obtained from Two Spices (Syzygium aromaticum and Cuminum cyminum).\u003cem\u003e\u0026nbsp;\u003c/em\u003e\u003cem\u003eInt. J. Food Prop\u003c/em\u003e\u003cem\u003e.\u0026nbsp;\u003c/em\u003e\u003cstrong\u003e19,\u003c/strong\u003e 2156-2164 https://doi.org/10.1080/10942912.2015.1110166 (2016).\u003c/li\u003e\n \u003cli\u003eBakour, M. \u003cem\u003eet al\u003c/em\u003e. The Antioxidant Content and Protective Effect of Argan Oil and Syzygium aromaticum Essential Oil in Hydrogen Peroxide-Induced Biochemical and Histological Changes. \u003cem\u003eInt. J. Mol. Sci.\u003c/em\u003e \u003cstrong\u003e19,\u003c/strong\u003e 610. https://doi.org/10.3390/ijms19020610 (2018).\u003c/li\u003e\n \u003cli\u003eG\u0026uuml;l\u0026ccedil;in, İ., Elmastaş, M. \u0026amp; Aboul-Enein, H.Y. Antioxidant activity of clove oil\u0026ndash;A powerful antioxidant source. \u003cem\u003eArab. J. Chem.\u003c/em\u003e\u003cstrong\u003e\u003cem\u003e5\u003c/em\u003e\u003c/strong\u003e\u003cstrong\u003e,\u003c/strong\u003e 489-499. https://doi.org/10.1016/j.arabjc.2010.09.016 (2012).\u003c/li\u003e\n \u003cli\u003eSoltani, M. \u003cem\u003eet al\u003c/em\u003e. The Effects of Clove Oil on The Biochemical and Histological Parameters, and Autophagy Markers in Polycystic Ovary Syndrome-Model RatsInt\u003cem\u003e. j. fertil. steril.\u003c/em\u003e \u003cstrong\u003e17,\u003c/strong\u003e187-194. \u003cu\u003ehttps://doi.org/\u003c/u\u003e10.22074/ijfs.2022.543640.1260 (2023).\u003c/li\u003e\n \u003cli\u003eLiu, B.B. \u003cem\u003eet al\u003c/em\u003e. Essential oil of Syzygium aromaticum reverses the deficits of stress-induced behaviors and hippocampal p-ERK/p-CREB/brain-derived neurotrophic factor expression. \u003cem\u003ePlanta. Med.\u003c/em\u003e \u003cstrong\u003e81,\u003c/strong\u003e 185-92. https://doi.org/10.1055/s-0034-1396150 (2015).\u003c/li\u003e\n \u003cli\u003eCarrasco, F.R. \u003cem\u003eet al\u003c/em\u003e. Immunomodulatory activity of Zingiber officinale Roscoe, Salvia officinalis L. and Syzygium aromaticum L. essential oils: evidence for humor- and cell-mediated responses. \u003cem\u003eJ. Pharm. Pharmacol\u003c/em\u003e. \u003cstrong\u003e61,\u003c/strong\u003e 961-967. https://doi.org/10.1211/jpp.61.07.0017 (2009).\u003c/li\u003e\n \u003cli\u003eDibazar, S.P., Fateh, S. \u0026amp; Daneshmandi, S. Clove (Syzygium aromaticum) ingredients affect lymphocyte subtypes expansion and cytokine profile responses: An in vitro evaluation. \u003cem\u003eJ. Food. Drug. Anal.\u003c/em\u003e \u003cstrong\u003e22,\u003c/strong\u003e 448-454. https://doi.org/10.1016/j.jfda.2014.04.005 (2014).\u003c/li\u003e\n \u003cli\u003eMatsui, T. \u003cem\u003eet al.\u003c/em\u003e Pulmonary aspergillosis in apparently healthy young rabbits. \u003cem\u003eVet. Pathol.\u003c/em\u003e \u003cstrong\u003e22,\u003c/strong\u003e 200-205. https://doi.org/10.1177/030098588502200302 (1985).\u003c/li\u003e\n\u003c/ol\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"scientific-reports","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"scirep","sideBox":"Learn more about [Scientific Reports](http://www.nature.com/srep/)","snPcode":"","submissionUrl":"","title":"Scientific Reports","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"Scientific Reports","inReviewEnabled":true,"inReviewRevisionsEnabled":true},"keywords":"Pulmonary aspergillosis, Clove essential oil, Rabbit, Microscopical findings","lastPublishedDoi":"10.21203/rs.3.rs-7941551/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-7941551/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003e\u003cem\u003eAspergillus\u003c/em\u003e is a genus of saprophytic fungi which is found in soil, construction equipment, and hospital environments. Invasive aspergillosis occurring in immunocompromised individuals or in patients receiving immunosuppressive therapy is recognized as a major cause of mortality. In the \u003cem\u003ein vitro\u003c/em\u003e phase of this study, clove essential oil was prepared by hydrodistillation of clove plant (\u003cem\u003eSyzygium aromaticum\u003c/em\u003e) dry powder, GC-MS analysis followed by the MIC and MFC determination of clove essential oil were performed. In the \u003cem\u003ein vivo\u003c/em\u003e phase, 24 female New Zealand White rabbits were exposed to a conidial suspension of \u003cem\u003eAspergillus fumigatus ATCC 13073\u003c/em\u003e via the endotracheal route after administration of non-neutropenic immunosuppressive agents (cyclosporine and methylprednisolone). The rabbits were then assigned into four groups: normal saline, Itraconazole, clove essential oil at 20 mg/kg, and clove essential oil at 10 mg/kg, administered orally every 24 hours. Daily monitoring of the rabbits was performed, and CT scans were conducted on days 0, 7, and 13 post-inoculations. On days 7 and 13 post-inoculation, half of the animals were sacrificed. Following this, Macroscopic examinations and sampling were conducted to evaluate bronchoalveolar lavage fluid and lung tissue fungal burden. For microscopical examinations of pulmonary lesions was used H\u0026amp;E staining, immunohistochemistry markers (CD68, CD163, and MPO), and Grocott\u0026rsquo;s methenamine silver (GMS) staining. Systemic toxicity in other vital organs was also assessed using H\u0026amp;E staining. The clove essential oil, containing 96.81% eugenol, demonstrated acceptable MIC and MFC activity for \u003cem\u003eAspergillus fumigatus ATCC 13073\u003c/em\u003e, comparable to Itraconazole. In both pre-mortem and post-mortem evaluations, the Itraconazole group and the clove essential oil group at a dose of 20 mg/kg exhibited significant reductions in fungal burden, fungal infection, and pulmonary involvement, without notable systemic toxicity changes in other tissues. Clove essential oil exhibited acceptable efficacy comparable to a commercial azole antifungal agent under both in vitro and in vivo conditions, effectively reducing the fungal burden of \u003cem\u003eAspergillus fumigatus ATCC 13073\u003c/em\u003e and associated pulmonary lesions without inducing systemic toxicity.\u003c/p\u003e","manuscriptTitle":"Pathologic Evaluation of Syzygium aromaticum Essential Oil Against Pulmonary Aspergillosis in Non-neutropenic Immunosuppressed Rabbits","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-11-18 12:34:01","doi":"10.21203/rs.3.rs-7941551/v1","editorialEvents":[{"type":"communityComments","content":0},{"type":"decision","content":"Revision requested","date":"2025-11-18T09:13:42+00:00","index":"","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2025-11-15T06:56:29+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2025-11-15T01:14:33+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2025-11-12T07:31:04+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"307354924132200347101418564003236703234","date":"2025-11-09T04:35:33+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"255637713580310507683409438115926901401","date":"2025-11-08T21:45:37+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"205342506378377621543262161747951809178","date":"2025-11-07T10:32:54+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"165300062947821944976289510359116592862","date":"2025-11-07T03:06:43+00:00","index":"hide","fulltext":""},{"type":"reviewersInvited","content":"","date":"2025-11-06T21:37:10+00:00","index":"","fulltext":""},{"type":"editorAssigned","content":"","date":"2025-11-06T21:19:58+00:00","index":"","fulltext":""},{"type":"editorInvited","content":"","date":"2025-11-06T13:13:06+00:00","index":"","fulltext":""},{"type":"checksComplete","content":"","date":"2025-11-03T10:06:36+00:00","index":"","fulltext":""},{"type":"submitted","content":"Scientific Reports","date":"2025-11-03T10:00:55+00:00","index":"","fulltext":""}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"scientific-reports","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"scirep","sideBox":"Learn more about [Scientific Reports](http://www.nature.com/srep/)","snPcode":"","submissionUrl":"","title":"Scientific Reports","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"Scientific Reports","inReviewEnabled":true,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"b23facfb-0860-48ae-9030-62c1ea65f63b","owner":[],"postedDate":"November 18th, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"published-in-journal","subjectAreas":[{"id":58037917,"name":"Health sciences/Diseases"},{"id":58037918,"name":"Biological sciences/Drug discovery"},{"id":58037919,"name":"Health sciences/Medical research"},{"id":58037920,"name":"Biological sciences/Microbiology"}],"tags":[],"updatedAt":"2026-01-05T16:01:46+00:00","versionOfRecord":{"articleIdentity":"rs-7941551","link":"https://doi.org/10.1038/s41598-025-34405-5","journal":{"identity":"scientific-reports","isVorOnly":false,"title":"Scientific Reports"},"publishedOn":"2026-01-03 15:58:20","publishedOnDateReadable":"January 3rd, 2026"},"versionCreatedAt":"2025-11-18 12:34:01","video":"","vorDoi":"10.1038/s41598-025-34405-5","vorDoiUrl":"https://doi.org/10.1038/s41598-025-34405-5","workflowStages":[]},"version":"v1","identity":"rs-7941551","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-7941551","identity":"rs-7941551","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}